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Abstract 
 
The recent progress in biomaterials science and development of tubular conduits (TCs) 
still fails in solving the current challenges in the treatment of peripheral nerve injuries 
(PNIs), in particular when disease-related and long-gap defects need to be addressed. 
Nanotechnology-based therapies that seemed unreachable in the past are now being 
considered for the repair and reconstruction of PNIs, having the power to deliver 
bioactive molecules in a controlled manner, to tune cellular behavior, and ultimately 
guide tissue regeneration in an effective manner. It also offers opportunities in the 
imaging field, with a degree of precision never achieved before, which is useful for 
diagnosis, surgery and in the patient’s follow-up. Nanotechnology approaches applied 
in PNI regeneration and theranostics, emphasizing the ones that are moving from the lab 
bench to the clinics, are herein overviewed. 
 
 
 
 
 
 
 
Keywords: Peripheral nerve regeneration; nanotechnology; nanomedicine; carbon 
nanomaterials; nanoparticles; nanofibers; nanoimaging; repair; tubular conduits. 
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Abbreviations: 6-mercaptopurine, 6MP; adipose-derived mesenchymal stem cells, 
ASCs; autologous nerve grafts, ANG; brain-derived neurotrophic factor, BDNF; 
Calcium titanate, CaTiO3; carbon nanofibers, CNFs; carbon nanotubes, CNTs; central 
nervous system, CNS; Chitosan, Cht; chitosan nanoparticles, ChtNPs; cholera toxin 
subunit B, CTB; Diacryalate, DA; dorsal root ganglion, DRG; extracellular matrix, 
ECM; esterquat 1, EQ 1; fluorescent nanodiamonds, fibroblast growth factor 2, FGF2; 
FND; Food and Drug Administration, FDA; glial cell derived neurotrophic factor, 
GDNF; gold, Au; graphene oxidized, GO; graphene oxide foam, GOF; heparinized 
cationic solid lipid nanoparticles,  HCSLNPs;  horizontally aligned carbon nanotube, 
HACNT; human endometrial stem cells, hEnSCs; human neural stem cells, hNSCs; 
hyaluronic acid, HA; induced pluripotent stem cells-derived neural crest stem cells, 
iPSCs-NCSCs; interleukin 10, IL-10; immunoglobulin domain-containing protein 1, 
LINGO1; magnetic NPs, MNPs; Magnetic Resonance Imaging, MRI;  mesenchymal 
stem cells, MSCs; menstrual mesenchymal stem cells, MenSCs; 
methylcobalamine, MeCbl;  microtube array membrane, MTAM;  molecular and 
cellular Magnetic Resonance Imaging, MCMRI; multi-walled carbon nanotubes, 
MWCNTs; nanobioglass, NBG; nanocrystalline diamond, NCD;  nanodiamonds, ND; 
nanoparticles, NPs; nerve growth factor, NGF; nerve guidance conduits, NGC; neuron-
penetrating peptide, RDP; neurotrophin-3, NT-3; nitrogen included ultra nanocrystalline 
diamond, N-UNCD; Peripheral nerve, PN; peripheral nerve injuries, PNIs; peripheral 
nerve regeneration, PNR; peripheral nervous system, PNS; perfluorocarbon, PFC; 
phosphate glass microfibers, PGFs; polyacrylamide, PAM; polyamidoamine, PAMAM; 
polyaniline, PA; polyaniline-graphene, PA-Graphene polycaprolactone, PCL; 
polydimethylsiloxane, PDMS; polyethyleneglycol, PEG; polyethyleneglycol-co-
polylactic acid, PELA; polyglycolic acid, PGA, Polyhydroxybutyrate, PHB; polylactide 
acid, PLA; Poly(L-lactic acid-co-ε-caprolactone), PLCL; polylactic-co-glycolic, PLGA; 
poly(L/D-lactic acid), PLDLA; poly-L-lactide, PLLA; poly-l-lysine, PLL; poly(methyl 
methacrylate), PMMA;  polypyrrole, PPy; polyvinylidenefluoride, PVDF;  poly(3,4-
ethylenedioxythiophene), PEDOT; poly (3-hydroxybutyrate-co-3-hydroxyvalerate), 
PHBV; retinal ganglion cells, RGC; retinoic acid receptor β, RARβ; silica, SiO2; silver, 
Ag; single-walled carbon nanotubes, SWCNTs; Schwann cells, SCs; Schwann cells 
basal lamina, SCBL; silk fibroin, SF; stearylamine, SA; superparamagnetic iron NPs, 
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SPIONs; three dimensional, 3D; Tissue engineering, TE; trimethylated chitosan, 
TMCht; ultra-small super paramagnetic iron oxide, USPIOs; vascular endothelial 
growth factor, VEGF. 
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1. Introduction 
 
Neurological defects are among the most common and demanding clinical situations 
despite decades of research in the neurological field [1]. The reason for this relies in the 
complexity of the nervous system functions, structure and anatomy, which makes it 
more challenging to treat as compared to other tissues in the human body [2].  
The nervous system comprises two components: i) the peripheral nervous system 
(PNS), and ii) the central nervous system (CNS). The PNS consists of the regions of the 
nervous system outside the CNS (brain and the spinal cord). The PNS includes cranial 
nerves, spinal nerves and their roots and branches, peripheral nerves (PNs), and 
neuromuscular junctions. Opposing to the CNS, the PNS is not protected by a hard bone 
layer or by the blood-brain barrier, making it much more disposed to traumatisms or any 
kind of injuries [3]. Therefore, PN injuries (PNIs) are considered a huge clinical burden, 
being the incidence 1 in 1,000 individuals per year [4]. In fact, PNI is associated to $150 
billion health-care expenses per year in the USA alone [5]. These costs are though 
underestimated, since “bed-days” and lack of productivity also account for monetary 
losses, worldwide. This scenario tends to worsen with the increasing world population 
and respective average lifespan. Considering those, an additional number of injuries 
tend to appear and consequently a high number of treatments and surgeries will be 
required to allow the restoration of the damaged nerves.  
In this scope, nanotechnology and nano-based materials have attracted a significant 
amount of interest from the scientific and medical community. These types of materials 
are considered a reliable alternative to tackle the main hurdles in PN regeneration 
(PNR). Although the CNS is vastly protected and therefore less prone to injuries, it has 
a limited ability to regenerate because of the succeeding scar tissue development which 
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can be created by a vast range of cell types, such as fibroblasts, neuroglia, monocytes, 
and endothelial cells [6]. In contrast, PNIs are considerably more common, but the PNs 
have a greater regeneration potential when compared to the nerves of CNS. This is 
because PNS glial cells, i.e. Schwann cells (SCs), tend to adapt to a regenerative 
phenotype and have the capacity of triggering neuronal regenerative processes, although 
usually slow and in a partial manner [7]. Given to their exposure, PN damages can be 
caused by many types of events, such as traumatic injuries, complications on surgeries, 
congenital defects and war wounds. Concerning the traumatic injuries, they can also 
vary significantly and include penetrating injuries, crush, traction, ischemia, and less 
common mechanisms such as thermal, electric shock and radiation [8]. Another 
common injury mechanism is compression, which may involve mechanical 
deformation, as well as ischemia. A vast range of diseases can also be the root cause of 
PNIs, as is the case of diabetic peripheral neuropathies [9, 10].  
In respect to the type of injury, small and long gaps must also be differentiated. This 
concerns the severity of the injury, as well as the outcome and the degree of recovery 
for the patient. 
In humans, for small gaps, which usually measure less than 30 mm, hollow lumen 
conduits can be used with rather good outcomes. However, reconstruction of gaps 
longer than 30 mm still remains a challenge nowadays. Nerve autografts and allografts 
still remain the clinically available options and the ones that provide the best chances of 
recovery [11]. However, when considering long gaps, most of the barriers to recovery 
remain unsolved, namely the slow regeneration rates and specificity of target 
innervation, which means that the distal stump is too far from the proximal. The 
degeneration of the target end-organ is another obstacle to a proper and functional 
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regeneration [12]. Therefore, the challenge presented by long gaps is the reason why 
innovative nanotechnology-based strategies are sought to be a good technological 
possibility. Figure 1 summarizes the main possible applications of nanotechnology 
approaches in an attempt to tackle some of the hurdles of PNIs. 
 
Figure 1 
Despite those seemingly good chances of recovery when using autografts, incomplete 
recuperation from PNIs usually lead to multiple negative consequences, which comprise 
numbness of affected members, chronic pain, diminishing of sensory and/or motor 
function and a disturbing permanent disability of the patients. It is a fact that these 
outcomes are unsatisfactory for the demands of today’s patient lives, since only 25% of 
patients regain proper motor function and less than 3% recuperate sensation in a full 
extent [13]. The outcome is a major loss of patient’s quality of life, both physically and 
mentally, and considering the above-mentioned facts, it is urgent to visualize PNIs as a 
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worldwide pertinent clinical problem [14]. Given the stated importance of PNI, the use 
of nanotechnology to help address and solve some of the challenges posed to clinical 
management of PNI is a field worthy to be explored and properly funded, and certainly 
will growth in the coming years. 
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2. PNIs: Fundamentals, current treatment options and challenges 
In order to make a preliminary evaluation, followed by a precise diagnosis and 
proceeding with the proper treatment of nerve injuries, it is imperative to have plain 
knowledge of nerve anatomy (Figure 2), as well as the neurobiological mechanisms 
that occur immediately after injuries. That is of utmost importance, since strategies to 
improve the outcomes following nerve injuries are often based on such biological 
mechanisms [15].  
The PNS is composed of motor and sensory neurons. Their cell bodies can be found 
within the spinal cord and their elongated cytoplasmic extensions, called axons, link and 
transmit the signals to the distant corresponding organ [5]. Figure 2A schematically 
represents the anatomy of the peripheral nerve. Anatomically, each individual axon is 
protected by the endoneurium, a layer of collagen and elastic elements. A group of 
endoneurium protects axon groups into nerve fascicles, which are sheathed by the 
perineurium, mainly composed of connective tissue. Finally, several fascicles are 
gathered together by the epineurium. External to this layer is the mesoneurium, 
containing the blood supply to the nerve. A fine network of capillaries exists at the 
endoneurial level [1, 5, 16]. Any break or defect in this stratified structure fallouts in a 
programmed and permanent cell death, unless rapidly and thoroughly reestablished [17, 
18]. 
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Figure 2 
The several degrees of injury to PNs are detailed in Table 1, which were firstly 
described by Seddon [19], and later by Sunderland [20]. The Seddon classification is 
divided into three categories according to the gravity of the injury: i) neurapraxia, 
ii) axonotmesis, and iii) neurotmesis. By its turn, Sunderland classification 
comprises five different categories: first, second, third, fourth and fifth degree. 
 
Table 1 - Seddon and Sunderland classifications of nerve injuries according to the 
pathophysiology of the nerve. 
Seddon 
classification 
Sunderland 
classification 
Process Degree of recovery 
Neurapraxia I 
Local myelin damage usually 
secondary to compression 
 
Full recovery 
Axonotmesis 
 
II 
Axon severed but endoneurium 
intact (optimal circumstances for 
regeneration) 
 
Full recovery 
III 
Axon discontinuity, endoneurial 
tube discontinuity, perineurium 
and fascicular arrangement 
preserved 
 
Wallerian degeneration, 
recovery incomplete 
IV 
Loss of continuity of axons, 
endoneurial tubes, perineurium 
and fasciculi; epineurium intact 
 
Wallerian degeneration, 
recovery incomplete 
Neurotmesis V 
Complete physiologic disruption 
of entire nerve trunk 
Wallerian degeneration, 
recovery incomplete 
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There are also three different types of PNs that should be considered for reconstruction 
after an injury: i) the motor neuron, ii) the sensory neuron, and iii) the mixed PNs [21]. 
Although all the three types of nerves are essential to carry a normal lifestyle, the motor 
and the mixed type of nerve are the ones that have major clinical importance in the 
reestablishment of the movement of the limbs. However, up to date, mostly sensory 
nerves are involved in the repair strategies due to easier harvesting, and relatively lower 
donor-site morbidity.  
Immediately after injury, the regeneration process of PNs runs in sequenced phases and 
different phenomena can occur at different levels on the injury site (Figure 2B), 
encompassing both proximal and distal sites [22]. In the proximal position, separated 
axons and cell bodies degenerate via a programmed cell death pathway called 
chromatolysis [23]. In the distal injury end, a process called Wallerian degeneration 
occurs at 24 to 48 hours after injury and all nerve components, such as distal axons and 
adjacent myelin starts to degenerate [24]. The goal of that phenomenon is related to the 
clearance of undesired debris. SCs phagocytize axonal and myelin debris, until only 
empty endoneurial tubes remain. SCs, which are the ensheathing glial cells of the PNS, 
are crucial for normal nerve function, nerve repair and constitute 90% of nucleated cells 
within PNs [25, 26]. After debris removal, they fill the empty endoneurial tubes and 
organize in characteristic bands or tubes of Bungner, and by this mean supporting the 
re-growth of axons. Not only SCs have a crucial role, but also macrophages are 
recruited to the area releasing growth factors and cytokines. They will stimulate SCs 
and fibroblast proliferation and are responsible for the axonal regeneration process [27]. 
Ahead in the process, in the proximal injury end, a growth cone emerges following the 
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path formed by the band of Bungner, which is of fundamental importance for the 
advance of the regenerating axon (Figure 2C) [28]. 
Considering the current state-of-the-art on nerve pathophysiology, only minor advances 
in medical and operating techniques have been made in the past years. Epineural repair 
remains the preferred surgical reconstruction when it is accomplished by direct tension-
free suture of both well-vascularized nerve ends [29]. Whenever that approach is not 
possible, due to excessive tension caused by elongating the nerves, and a gap remains, 
these lesions do not spontaneously regenerate. In such cases, autologous nerve grafts 
(ANG) become the gold standard treatment for nerve restoration [30]. However, ANG 
cannot guarantee an absolute functional outcome for the patient. Problematic 
consequences, such as unavailability of appropriate-sized nerves and donor site 
morbidities, sensibility abnormalities and painful conditions are also frequently 
associated to this type of approach [30]. 
An alternative option to use in nerve transplantation is cadaveric allografts [31]. 
However, like ANG, there are pros and cons regarding the use of allografts. The 
selection of the type of graft is based on the patient’s needs and typically it involves a 
systemic immunosuppression therapy in the patient for long periods of time [32]. 
For these reasons, increasing efforts have been made over the last decades in the search 
for effective alternatives to ANG. Tissue engineered tubulization has been a widely 
explored alternative to bridge the nerve gap and throughout the years many types of 
nerve guidance conduits (NGC) were proposed, being some of them already approved 
by the Food and Drug Administration (FDA) [33, 34]. Since mature neurons are not 
susceptible to mitosis phenomena, it is crucial to support the re-growth of the existing 
cell bodies, providing a protective environment and guiding paths. In this way, it is 
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possible to direct axons from the proximal do the distal site, permitting the proper 
linking of the damaged synapses connections. In brief, the protection of the injury site 
and performance as a guidance substrate are the two main reasons why tubulization is 
used in PNIs. 
In the early use of conduits made of synthetic materials in the clinics, they were mainly 
composed by silicon tubes and could only repair injuries up to 10 mm. Some 
disadvantages on the use of that conduits included total lack of biodegradability, which 
led to inflammation and chronic foreign body reaction, as well as lack of swelling 
capacity, which would compress the nerve, thus hindering the regeneration process [35]. 
In order to overcome such difficulties, biodegradable nerve guidance conduits have 
been proposed, some of which are FDA-approved and being currently used in the 
clinical setting [34]. Nevertheless, despite the major advances achieved with the use of 
silicon conduits, most NGCs are hollow tubes and can only repair short nerve gaps. 
In 2014, however, there was a breakthrough regarding this subject. The first conduit 
integrating a luminal filler acting as three dimensional (3D) guiding and supporting 
scaffold was approved. NeuraGen® 3D nerve guide matrix is composed by collagen I, 
whereas the luminal filler comprised of collagen I and glycosaminoglycan chondroitin-
6-sulfate, with aligned porosity acts as a topographical cue for regenerating axons. 
In vivo data demonstrated significantly improved regeneration as compared to an empty 
conduit [36]. 
In the past decades, numerous NGC made of both synthetic and natural biomaterials 
have been described. Regarding the synthetic materials, these are still considered very 
promising since the majority of the FDA-approved nerve guidance conduits are 
composed of materials such as polyglycolic acid (PGA), polylactic-co-glycolic (PLGA), 
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polycaprolactone (PCL) [34]. Polyhydroxybutyrate (PHB) has been reported to have 
neuroprotective features and support axons regrowth [37]. Among the natural-based 
biomaterials, polysaccharides such as chitosan (Cht) [38, 39] and alginate [40] have 
been also considered as promising materials due to their worthy results in the scope of 
PNR. Still among the natural-origin biomaterials, extracellular matrix (ECM) 
endogenous proteins such as collagen [41], fibrin [42], laminin [43, 44], and hyaluronic 
acid (HA) [45] have been highly investigated, since they all naturally exist in the human 
body.  
Not only the type of biomaterial used in the NGC is important, but its architecture is 
also an important feature. There is still no consensus in the scientific community on 
whether the conduit should remain empty [46] or filled with any kind of materials [47], 
such as hydrogels [48], nanofibers [49] or films [50]. An empty lumen has the 
advantage of allowing free space for nerve regeneration, so that the axons may 
selectively re-innervate the appropriate target. Conversely, a lumen filled with any type 
of topographical and biological cues can provide a supporting structure that may favor 
cells ingrowths and guidance [1, 51].  
Apart from the use of NGC and fillers, systemic or localized delivery of neurogenic, 
anti-inflammatory and pro-angiogenic factors should be ideally performed. Among 
those, cytokines, drugs or stem cell therapies can be considered in order to enhance the 
neurofunctional outcomes [52]. It is important to point out that these strategies work by 
different mechanisms and distinct biochemical pathways. Therefore, a proper 
combination of a promising NGC, guiding fillers, with cellular therapy and localized 
delivery of factors will most definitely match the results usually obtained with ANG. 
Although PNS has a certain ability to regenerate, other physiopathological phenomena 
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impair nerve regeneration and these are presented as the great challenges that need to be 
overcome to succeed in PNR. Also, most of the strategies being developed are focused 
on the specific injury site [53]. Other scientific solutions should be sought in order to 
address problems that emerge after the injury itself and focus on maintaining distal 
axonal and muscular target integrity.  Also, it must be guaranteed the survival of cell 
bodies in the proximal site, occurrence that remains largely unexplored and would 
essentially contribute to maintain the natural physiology after injury.  
Therefore, other therapies or approaches should be taken in consideration to address 
simultaneously what happens in the nerve gap itself, but also, upstream and downstream 
of that location. This is where novel nanotechnologies, including for instance, 
nanoparticles (NPs), nanoimaging and carbon nanomaterials start to take a key role in 
cutting-edge approaches that might be able to solve problems that could not be 
addressed with traditional methods. Taking a closer look to some nanotechnologies, one 
can immediately understand their potential in PNR. In one hand, the refinement of 
NGC’s technologies lies in the incorporation of nanotechnological techniques. On the 
other hand, nanotechnological approaches can be used on their own [54]. 
Because of their properties and competences, NPs have an immense broad of 
applications in PNR. They can not only carry every type of growth factor or 
biomolecules of interest to the desired place but can also deliver it with the appropriate 
kinetics for an optimal result. This has been a problem that scientists have been trying to 
address for years, since mimicking the natural events by the correct delivery of 
biological factors is crucial for an efficient regeneration [55]. Further than that, they 
comprise the basic nanoimaging tools, such as MRI (magnetic resonance imaging) 
allowing visualization techniques never achieved before in the clinics [56]. Carbon 
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nanomaterials, such as carbon nanotubes, are another exciting example of multiple-
advantageous materials for PNR, encouraging the scientists to achieve goals that take 
PNR to another level. Since PNS relies on electric conduciveness, not only can they be 
used for coating electrodes for interfacing neurological prosthesis, but they can simply 
integrate tubular conduits making them also electrically conductive [57]. In addition to 
providing a permissive substrate for neuronal growth, patterned carbon nanotubes 
substrates are also able to control the direction of neurite outgrowth and participate in 
the organization of neural networks, as the misdirection of growing axons is still an 
intriguing problem for surgeons and scientists. 
First of all, engineering a NGC should aim at facilitating cellular spreading and growth 
of damaged nerve tissues in 3D [58]. Other than that, it is crucially important that the 
material envisioned to be used to construct the NGC is cytocompatible and has 
pronounced biomechanical properties. If an engineered NGC does not present a proper 
cytocompatibility, may not contribute to the growth of damaged nerves, but would 
instead be the reason of acute inflammation and even infection [59]. It must exhibit 
good biocompatibility with low inflammatory and immunogenic reactions [14]. It must 
also be biodegradable, and ideally degrade in the same rate as nerve regenerates. 
Otherwise, a quick degradation might trigger an inflammatory response [58, 60]. 
Regarding the mechanical properties, the NGC should provide sufficient mechanical 
strength to prevent the NGC rupture during the patient’s movements and physically 
support neural tissue regeneration. Concurrently, the NGC should have appropriate 
elasticity to be able to lessen tensions in the damaged area [59]. Furthermore, the 
materials used to construct NGC should prevent the migration of fibroblasts that will 
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lead to the formation of glial scar tissue around the implant, which could reduce the 
healing chances [61].  
The permeability of a conduit is also an important parameter to consider in the TCs 
design as both nutrients and oxygen must diffuse into the site of regeneration. 
Otherwise, cells inside the conduit, especially if it is a long conduit, will be under a 
deleterious ischemic environment which can result in cellular hypoxia and lack of 
proper nutrients. Ideally, electrical conductivity would be preferred for a NGC used in 
neural tissue engineering (TE) in order to mimic the electrical properties of nerves and 
at the same time excite the neuron communication [62]. Succinctly, an ideal NGC 
should be biocompatible, biodegradable, flexible, compliant, porous, neuroconductive 
and with suitable surface and mechanical properties. However, even if all these criteria 
were successfully gathered in a developed NGC, there are some complications that are 
difficult to avoid and that reduce the chances of regenerative success. This section 
unfolds some of the most important physiopathological phenomena (e.g. inflammatory 
response, fibrosis or scar tissue formation, and lack of proper vascularization) that 
prejudice PNR and should be addressed to achieve a successful nerve recovery as 
overviewed in Table 2. A schematic of such events can also be seen in Figure 3. 
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Figure 3 
Neuroinflammation is an important phenomenon in nerve degeneration and consequent 
regeneration and is intrinsically associated with PNIs. It is a lively and active process 
that changes throughout the sequence of recovery. Both the timing and grade of 
inflammation will either result in the improvement or obstruction of the regeneration 
process. This process also significantly varies between individuals, which makes it 
harder to control [63]. 
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Table 2 - Phenomena prejudicing peripheral nerve regeneration. 
Phenomena impairing PNR Related features Cells/molecules involved 
Inflammatory response 
- Inflammatory response is always involved 
after an injury 
- Timing and inflammation severity l 
influence regeneration process 
- Process varies between individuals  
 
- Macrophages that can be either M1 
(anti-inflammatory) or M2 pro-
inflammatory 
- IL10 (anti-inflammatory cytokine) 
Fibrosis or Scar tissue formation 
- Intraneural fibrosis will prevent the 
passage of axons from the proximal 
segment to the distal segment- Extraneural 
fibrosis limits the physiological movement 
of nerves during the patients’ movement 
- Excessive fibrosis results in painful 
adhesions 
 
- Fibroblasts (fibrotic tissue 
deposition) 
- IL-10 (support scarless healing) 
Lack of vascularization 
- The relationship between vascularization 
and neural TE has been recognize as early 
as 1990 
- Lack of vascularization leads to ischemia 
and consequent cell death by lack of 
oxygen and nutrients  
- VEGF 
- Macrophages 
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The immune system plays a critical role during nerve regeneration and an inflammatory 
response is always involved after an injury. As SCs release cytokines and chemokines, 
different immune cell types are recruited to the critical place in the first hours after the 
traumatic event, including granulocytes (neutrophils and mast cells) and agranulocytes 
(monocytes/macrophages and lymphocytes) [50, 64]. Controlling the inflammation that 
occurs in the neurodegenerative scene is a highly complex problem that requires patient-
specific interventions. Recently, investigations in the area of nanotechnology have been 
trying to address that problem [65]. Considering the neuroinflammation process as 
something to take advantage of, and by marking macrophages with specific NPs, one 
could retrieve information about the biodistribution of drugs, treatment efficacy and 
assessment on possible toxicity in a real-time manner, with consequent improved 
therapeutic intervention. 
Along with SCs, macrophages play the most crucial role after an injury, intrinsically 
connected to Wallerian degeneration. These cells can assume two phenotypes (Figure 
3A): i) pro-inflammatory, being designated as M1, and ii) anti-inflammatory/pro-
healing, being in this case designated as M2, phenotypes, which change during the 
course of the injury [66, 67]. However, endogenous mechanisms exist that intend to 
control PNI inﬂammation, such as the release of cytokine interleukin 10 (IL-10) [68]. 
Also, SCs remyelination of regenerated axons stimulates macrophage removal. Still, 
these mechanisms are not efficient enough and prolonged or chronic inﬂammation 
becomes deleterious and a challenge during PNR [69]. 
Fibrosis or scar tissue formation around the implant is another expected and natural 
occurring event after an injury [70]. However, depending on its extension, it might be 
critical for nerve regeneration since excessive deposition of ECM and consequent 
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remodeling lead to the formation of permanent scars. Fibrosis can hinder regeneration in 
two ways: i) intraneural fibrosis will prevent the passage of axons from the proximal 
segment to the distal segment, and ii) extraneural fibrosis limits the physiological 
movement of nerves during the patients’ movement, leading to pain and functional 
limitation (Figure 3B) [71]. Moreover, it was reported that IL-10 supports scar less 
healing in postnatal tissue, acting as an adjuvant in combating the excessive fibrosis 
formation that prevents the correct process of regeneration [72]. 
Lack of proper vascularization, i.e. the deficiency of angiogenesis process in the injured 
site, has lately been considered as one of the main factors limiting nerve regeneration. 
The relationship between vascularization and neural TE has been recognized as early as 
1990 [73]. After nerve reconstruction, the nerve is subjected to ischemic conditions, 
which potentially alters the regenerative environment and outcome across the bridge or 
graft [74]. Tissues subjected to prolonged ischemia are associated to abundant 
pathological processes, including cell damage and dead, due to the lack of oxygenation 
and nutrients’ supply. This has been considered an explanation for the poor regenerative 
outcomes of engineered grafts, since a delayed re-vascularization has been observed, in 
comparison to normal autografts that re-vascularize much faster [75]. However, the 
beginning of the regeneration process (e.g. Wallerian degeneration and SCs 
arrangement in band of Bungner) is initiated by hypoxia [76]. Such phenomena are 
selectively sensed by macrophages that start to secrete vascular endothelial growth 
factor (VEGF), inducing a polarized vasculature that relieves from hypoxia. SCs 
then use the blood vessels as physical guiding cues to migrate through the gap and bring 
regenerating axons along the way (Figure 3C). 
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3. Nanotechnology approaches for functionalization of tubular conduits  
With the rising application of nanotechnology in every sector of our daily lives, the 
demand for the development of novel nano-scaled (< 100 nm) approaches is growing at 
an incredibly rate [77]. The use of nanotechnology and nano-based materials is widely 
spread in a variety of sectors, such as healthcare [78], electronics [79], cosmetics [80], 
agriculture [81] and the continuous improvement and innovation in the field is 
perceived as an extraordinary opportunity for significantly improve treatment and 
diagnosis of PNIs [82]. Thus, the application of precisely engineered nanomaterials that 
can be used in all stages of illness: prevention, diagnosis and therapy, including 
neurological pathologies is now attracting a great deal of attention [83]. The ultimate 
advantage of nanomaterials applied in medicine is based on their ability to interact with 
biological systems, which takes place at a molecular level with a high degree of 
speciﬁcity. This translates on the ability of such materials to migrate through cell 
membranes, amplified solubility, steadiness and bioavailability of biomolecules, thereby 
enhancing their delivery competence [83].  
Therefore, besides the incorporation of nanomaterials in scaffolds with the aim of 
boosting their properties, the application of nanomaterials alone can be done for 
bioimaging [84] and targeted delivery of desired specific molecules into cells 
[70]. Another major advantage of nanomaterials is their nano-roughness resemblance to 
ECM [85]. In this sense, nanomaterials reproduce what happens at a nano-scale level in 
the human body, being therefore regarded as the ultimate biomimetic materials.  
Although, nanotechnology has played a huge role in PNR in recent years, both problems 
of short and long gaps are being simultaneously addressed by means of developing 
advanced nanosystems (e.g. aligned nanofibers [86, 87] or carbon nanotubes [88-90]) 
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that can act as guiding cues and direct and stimulate the correct re-growth of axons. 
Advances in nanomedicine field applied to PNR are expected to have a major impact in 
the patient’s recovery and quality of life, since novel therapeutic strategies are evolving 
and reflecting the interdisciplinary and integrated treatment strategies that bring together 
nanotechnology and TE [91].  
Among the variety of available nanomaterials existing and the hundreds of thousands of 
publications in the area, the most promising works reporting on nanomaterials and 
offering remarkable advances in the field of PNR were selected and are reviewed 
herein.  
3.1. Carbon nanomaterials 
 
Carbon nanomaterials were projected as encouraging candidates for many industrial and 
technical purposes many decades ago. Worldwide commercial interest in carbon 
nanomaterials is reflected in its extreme production every year. Diverse commercial 
products ranging from batteries, motorized components, sporting goods, any kind of 
structural material and even agricultural products have nanomaterials in their 
composition now-a-days [92, 93]. Only after that initial burst in other areas, their 
potential for biomedical applications was realized [94]. That was due to their great 
properties that were envisioned as very useful when combined with other biomaterials 
in TE approaches [95].  
Carbon nanostructures were proposed as promising candidates to develop neural 
scaffolds. When considering neuronal regeneration, electrical stimulation, as well as 
appropriate electrical conductivity of the applied biomaterials, have been considered 
one main advantage since the natural PNS is capable of easily transmitting electrical 
impulses [96, 97]. Furthermore, carbon materials are mainly composed of the very basic 
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element existing in all things, e.g. carbon. Currently, the best-known carbon 
nanostructures belong to four different categories: carbon nanotubes (CNTs), graphene, 
carbon nanofibers (CNFs), and nanodiamonds (ND). Figure 4 depicts some of the most 
interesting results concerning the section of carbon nanomaterials, which will be 
discussed in depth. 
 
Figure 4 
3.1.1. Carbon nanotubes 
Carbon nanotubes (CNTs) represent one of the most studied allotropes of carbon. CNTs 
are sheets of graphite rolled into cylindrical tubes, built from a hexagonal arrangement 
of sp2-hybridized carbon atoms in nano-scale dimensions and were first introduced by 
Iijima [98]. They can be mainly divided in two categories depending on the number of 
shells: single-walled carbon nanotubes (SWCNTs), with diameter ranging between 0.8-
2.0 nm and multi-walled carbon nanotubes (MWCNTs), with diameter ranging from 2.0 
and 100 nm. Scheme of such CNTs can be seen in Figure 4AI. 
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There are numerous methods for CNTs production, that mainly include electric 
discharge [98], laser ablation [99] and chemical vapor deposition [100]. Some of the 
exciting features of CNTs include their extreme mechanical, thermal, magnetic, optical, 
electrical, surface, and chemical properties. The combination of these characteristics 
enlarges the range of possible biomedical applications where they can be applied 
[101]. As previously mentioned, besides being in the nano-scale range, the most 
attractive feature of such materials relies on their ability to display metallic and 
superconducting electron transport properties. However, original CNTs do not own the 
necessary solubility for being used in biomedical applications. Therefore, it is critical to 
functionalize CNTs not only to make them more soluble, but to allow their integration 
into many organic, inorganic, and biological systems and applications. Two main 
strategies have been identified to allow the application of CNTs under physiological 
conditions, which rely on covalent and non-covalent functionalization [102]. With such 
modifications, CNTs can be used in several biomedical applications, such as drug 
delivery, diagnostics, biosensors, biomedical imaging, as well as TE and regenerative 
medicine. 
The diameter of an individual CNT (1–100 nm, depending on the number of walls) is 
comparable to that of a single protein complex, such as a microtubule (25 nm diameter), 
which forms the basic structural element of the neuronal cytoskeleton [103]. However, 
these carbon nanomaterials have many extraordinary features to be applied in neuronal 
repair, namely: (1) are chemically stable and inert, being also biocompatible due to their 
carbon composition; (2) have nano-scale topography mimicking neural tissues (e.g. 
neurites); (3) enable intracellular permeation for delivery of biomolecules; (4) interact 
with neuronal cells, i.e. by means of promoting cell attachment, differentiation and 
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growth by overall supporting neurite elongation and branching being internalized by 
neuronal cells, as PC12, Schwann or SH-SY5Y and to guide them; (5) enable to expose 
neuronal cells to different kinds of stimulus, according to the properties of the applied 
carbons materials; (6) are cell-friendly allowing neuronal cells adhesion and 
proliferation; and (7) have bulk electrical properties in accordance with native neuronal 
tissues [101, 104].  
The exact role of CNTs in PNR have not been defined yet but is mainly related to 
enhancing axon growth rates via electrical stimulation and contact guidance cues, as 
well as providing structural reinforcement of NGCs. Also, CNTs could be used for 
localized delivery of growth-promoting molecules [105].  
The first report on the application of CNTs in the field of neuronal research was 
published in 2000 by Mattson et al. [106]. In that work, embryonic rat-brain neurons 
were grown on MWCNTs and it was observed that on unmodified nanotubes, neurons 
extend only one or two neurites. By its turn, nanotubes coated with the bioactive 
molecule 4-hydroxynonenal, allowed neurons to develop multiple neurites and display 
extensive branching. These findings establish for the first time the feasibility of using 
CNTs as substrates for nerve cell growth. 
Ever since, several works have already demonstrated the significant and profound 
effects of CNTs in PNR, opening the path for further research [105, 107-111]. In Table 
3, the main uses of CNTs in PNR are summarized [88-90, 112-120].  
In 2014, Roberts et al., [112] have produced horizontally aligned carbon nanotubes 
(HACNT) on both ﬁlm substrates and ﬂat glass coverslips. The HACNT substrates were 
found to support the growth of primary embryonic rat motor neuron for up to eight days 
in serum-free culture. Importantly, major neurites were more likely to be oriented 
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parallel to the aligned CNTs. In the same year, Yu et al., [88] combined the superior 
properties of MWNTs with collagen/PCL nanofibers produced by electrospinning. The 
aim was to evaluate the mechanical effects and efﬁcacy of MWNTs on the electrospun 
nerve conduit, as well as their biocompatibility and toxicology when applied in vivo. 
Their studies 
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Table 3 - The use of carbon nanotubes applied to peripheral nerve regeneration. 
Type of carbon nanotube Cell type and/or animal model Main results References 
MWCNTs Primary embryonic (E15) rat Motor Neuron 
Major neurites are more likely to be oriented parallel to the 
aligned CNTs 
 
Roberts et al., 2014 
[112] 
Nanofibers reinforced with 
MWCNTs 
Schwann cells; sciatic nerve defect in rat 
In vitro support of Schwann cell adhesion and elongation and 
in vivo promotion of sciatic nerve regeneration in rat 
 
Yu et al., 2014 [88] 
Chitosan-aligned MWCNTs 
composite 
HT-22 hippocampal neurons 
Improvement of mechanical properties, electrical conductivity 
and in vitro alignment of hippocampal neurons  
 
Gupta et al., 2015 [90] 
Chitosan-MWCNTs 
L929 fibroblasts and mHippoE-18 
hippocampal cells  
Both SWCNTs and MWCNTs can be incorporated with an 
electrodeposited phenomenon and cytocompatibility was 
proved between these materials and cells  
 
Nawrotek et al., 2016 
[113] 
Chitin/CNTs nanofibrilar structure PC12 cells and RCS96 cells  
Three different concentrations of CNTs were used, being the 
one with 5 wt% the most successful one. PC12 and RCS96 
cells were used to test the biocompatibility with promising 
results 
 
Wu et al., 2017 [114] 
CNT-interfaced Phosphate Glass 
Fibers 
PC12 cells, DRGs; sciatic nerve defect in rat 
Carbon nanotubes were successfully interfaced on phosphate 
glass fibers for nerve guidance and then implemented into a 3-
D scaffold which possessed physicochemical integrity with 
good cell viability and neuronal interactions  
Ahn et al., 2015 [89] 
SWCNTs in collagen type I-10% 
Matrigel™ composite hydrogel 
DRGs 
Presence of SWCNTs was beneficial due to increased 
electrical conductivity 
 
Koppes et al., 2016 
[115] 
Nanocomposite where MWCNTs, 
were dispersed in a poly-L-lactic acid 
matrix 
SH-SY5Y cells 
The combination of the nanocomposite scaffold and such 
peptides proved to synergistically boost neuronal 
differentiation of SH-SY5Y 
 
Scapin et al., 2015 
[116] 
Poly-PEDOT and MWCNTs coated 
on the electrode surface 
Coated and un-coated electrodes were 
implanted on rats DRGs 
In vivo model involving stimulation of DRGs Coated 
electrodes revealed healthier neurons after stimulation 
 
Kolarcik et al., 2015 
[117] 
Gold-CNTs electrode Electrode place in rat sciatic nerve Amongst the several formulations, the electrode made of gold- Xue et al., 2015 [118] 
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CNTs has significant lower impedance and dramatically 
increases the signal recording resolutions  
 
Residual rubber shielded 
MWCNTs 
 
NIH3T3 fibroblasts and human 
neuroblastoma cell line, SH-SY5Y 
Neuroblastoma cells revealed amplified filopodia growth in 
comparison to unetched surfaces and silicone rubber 
 
Tegtmeier et al., 2016 
[119] 
MWCNTs-PDMS Schwann cells and DRGS 
Two-fold increase in the viability and proliferation of the 
neural cells and Schwann cells using the PDMS/MWNT sheet 
Kang et al., 2015 [120] 
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revealed that carboxyl MWNTs could greatly alter the nanofibers’ physicochemical 
properties, such as hydrophilicity, mechanical properties and degradability. The carbon 
materials were also able to support SCs adhesion and elongation in vitro. In in vivo 
studies, MWNT-enhanced collagen/PCL conduits were shown to effectively promote 
nerve regeneration of sciatic nerve defect in rats and prevent muscle atrophy without 
promoting body rejection or serious chronic inflammation, evidencing the potential of 
this biocomposite NGC. 
In 2015, Gupta et al. [90], achieved the challenging task of aligning MWCNTs in a Cht 
scaffold, producing an anisotropic conductive MWCNTs-Cht composite scaffold 
fabricated using electric field alignment technique. Not only the mechanical properties 
greatly improved with the incorporation of 0.5 wt% of aligned MWCNTs, but electrical 
conductivity increased 100,000 times along its direction. When tested in vitro, 50–60% 
of HT-22 hippocampal neurons were aligned in the MWCNTs alignment direction of 
the scaffold with increasing viability over time. With the same materials, Nawrotec et 
al., [113] developed a new straightforward method for obtaining Cht–CNT implants 
enriched with calcium ions in the form of tubular hydrogels. Both SWCNTs as well as 
MWCNTs can be incorporated by an electrodeposited phenomenon. Additionally, 
hydroxyapatite was added once it has been proved to increase neuronal growth due to 
the increase of calcium concentration. L929 fibroblasts and mHippoE-18 hippocampal 
cells were tested in pro-inflammatory tests to reveal the cytocompatibility of such NGC 
intended for PNR. 
Both Cht and chitin have been proposed as components of composites containing CNTs, 
despite their poor solubility. Wu et al., [114] developed chitin/CNTs composite 
hydrogels by dispersing CTNs in chitin previously dissolved in sodium hydroxide/urea 
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aqueous system. The resulting hydrogels exhibited nanofibrillar network with 
outstanding mechanical properties. Three different concentrations of CNTs were used, 
being the 5 wt% the most successful concentration showing promising results in terms 
of biocompatibility when using PC12 and RCS96 cells.   
In the work of Ahn et al., [89] aminated CNTs were chemically linked onto the surface 
of aligned phosphate glass microfibers (PGFs), as shown in Figure 4B. Then, CNT-
interfaced PGFs (CNT–PGFs) were successfully placed into 3D poly(L/D-lactic acid) 
(PLDLA) porous tubes, by wrapping the CNTs-PGFs onto a PLDLA nanofiber mesh 
and embedding in a porous PLDLA tube afterwards. This composite scaffold, although 
effective in restoring motor functions as observed by electrophysiological studies, it did 
not provide better conditions than those of ANG. 
Koppes et al., [115] also envisioned to use SWCNTs to manipulate the bulk electrical 
properties of a collagen type I-10% Matrigel™ composite hydrogel. The researchers 
tested the effect of the presence and absence of SWCNTs, as well as the beneficial 
effects of electrical stimulation or the lack of it. In fact, electrical stimulation and 
SWCNTs-loaded biomaterials resulted in a 7.0-fold increase in outgrowth relative to the 
unstimulated, nanofiller- free controls, as seen in Figure 4C. 
In a more complex approach, Scapin et al., [116] developed a nanocomposite scaffold, 
where MWCNTs were dispersed in a poly-L-lactic acid matrix, contributing to provide 
electrical cues and mimic neural topography. Furthermore, to mimic guidance cues and 
the natural neuronal environment, biomimetic peptides reproducing active motifs from 
L1 and Leucine-rich repeat and immunoglobulin domain-containing protein 1 
(LINGO1) proteins were incorporated. These peptides control neurite outgrowth, 
adhesion, myelination and axon guidance. The combination of the nanocomposite 
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scaffold and such peptides proved to synergistically boost neuronal differentiation of 
SH-SY5Y. 
Kolarcik et al., [117] aimed to construct a neural electrode capable of in situ stimulation 
of the rat dorsal root ganglion (DRG). For that, authors used the conductive polymer 
poly(3,4-ethylenedioxythiophene) (PEDOT) and MWCNTs, which were coated on the 
electrode surface and doped with dexamethasone. In fact, results showed that coated 
microelectrodes have lower in vitro and in vivo impedance values. Signiﬁcantly less 
neuronal damage was observed with coated electrodes as compared to non-coated 
controls. The inﬂammatory response with the PEDOT/CNT-coated electrodes was also 
reduced, demonstrating the advantage of including MWCNTs in such devices. 
In field of electrodes for recording PNs signals, Xue et al., [118] developed a novel 
polyimide-based C-shaped neural interface electrode. Amongst the several formulations, 
the gold-CNTs made electrode had significant lower impedance values and dramatically 
increased the signal recording resolution, when compared to CNTs-free electrodes. 
Tegtmeier et al., [119] developed an active neural implant by immersing MWCNTs in 
silicone rubber and re-etching the surface. Since rubber presents toxic substances, 
residual rubber was reduced to an estimated layer of only 13 nm covering the CNTs and 
thus securing them to the electrode material. Impedance measurements confirmed the 
etching success. NIH3T3 fibroblasts and human neuroblastoma SH-SY5Y cell lines 
were used to prove the adequate biocompatibility of the neural implant. Inclusively, 
neuroblastoma cells also revealed amplified filopodia growth in comparison to non-
etched surfaces and silicone rubber.  
Kang et al., [120] studied the applicability of MWCNTs mixed with 
polydimethylsiloxane (PDMS) sheet to promote primary neuronal cells proliferation, by 
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incorporating MWCNTs in PDMS using a simple printing transfer method. The results 
showed increased mechanical properties and roughness, as well as superior 
electroconductivity when compared to PDMS sheets alone. The developed material 
increased adhesion and proliferation of primary DRGs, as well as SCs, in a higher 
extent when compared to poly-l-lysine (PLL) coated dishes, which are commonly used 
to increase cellular attachment. 
The downside of the use of carbon nanomaterials for PNR relies in their toxic nature 
[121]. Their physicochemical properties could make them toxic for living organisms or 
the environment [122]. Mechanisms of toxicity include membrane damage, DNA 
damage, oxidative stress, changes in mitochondrial activity and altered intracellular 
metabolic routes [122]. 
CNTs have a highly hydrophobic surface and a non-biodegradable nature that 
contributes to their reduced biocompatibility, limiting their application in the 
biomedical field, with growing concerns about their chronic toxicity [122].  
Presently, there are controversial results regarding carbon nanomaterials toxicity, as 
some publication reported that carbon materials are toxic for neuronal-related cells. For 
instance, MWCNTs seem to inhibit neuronal differentiation of PC12 cells [123] and 
SH-SY5Y [124]. Moreover, Wu et al., [125] reported that exposure of DRG cultures to 
MWCNTs compromises regenerative axonogenesis [125]. Additionally, respiratory 
toxicity is the main concern when carbon nanomaterials are used [126, 127]. 
Nevertheless, many other works report non-toxic effects both in in vivo and in vitro [88, 
114]. Meanwhile, it was reported that MWNTs are likely to be a more neural-friendly 
interface than SWNTs, since they allow for a wider external surface and effective 
functionalization [128]. What is important to state is that before transposing carbon-
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based nanotechnology to the clinics, scientists must be critical in assessing its possible 
toxicity. 
3.1.2. Graphene   
Graphene belongs to one of the allotropic forms of carbon. This two-dimensional planar 
monolayer nanomaterial composed of SP2-bonded carbon atoms is by norm arranged in 
a honeycomb form with carbon to carbon interatomic length, also possessing a number 
of amazing mechanical, optical and conductive properties [129]. The intensive research 
on the biological applications of graphene and its derivatives is based on its several 
fascinating properties, such as high specific surface area (2,630 m2/g), exceptional 
electric conductivity, thermal conductivity (~5,000 W/m/K), mechanical strength 
(Young’s modulus, ~1,100 GPa), intrinsic biocompatibility, low cost and scalable 
production, and facile biological/chemical functionalization of graphene oxide [130]. In 
its elementary form, graphene can also be used to aid in PNR. However, due to the fact 
that the surface of graphene lacks functional groups, it is difficult to dissolve in solvent 
and can easily agglomerate. Therefore, in many works, graphene oxidized (GO) is used, 
since its surface is rich in functional groups containing oxygen [131]. Table 4 
overviews the works showing the application of graphene in PNR [132-142]. 
Li et al., [132] developed a GO/polyacrylamide (GO/PAM) composite hydrogel 
fabricated by in-situ free radical polymerization. The GO/PAM composite hydrogel 
with 0.4% GO could effectively enhance the attachment and proliferation of SCs and 
release higher amounts of growth factors and larger matrix adsorption than other 
samples with different amounts of GO. 
Baniasadi et al., [133] were responsible for the development of a porous conductive 
Cht/gelatin scaffold containing polyaniline/graphene (PA-Graphene) nanocomposite. 
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The effects of PA-Graphene content showed that the electrical conductivity and 
mechanical properties increased proportionally to the increase in PA-Graphene loading, 
while the porosity, swelling ratio and in vitro biodegradability decreased. Overall, the 
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Table 4 - The use of graphene applied to peripheral nerve regeneration. 
Type of graphene nanomaterial Cell type or animal model Main results References 
Graphene/hydrogel Schwann cells 
GO/PAM composite hydrogel with 0.4% GO enhanced the attachment and 
proliferation of Schwann cells  
 
Li et al., 2016 [132] 
Conductive Graphene nanoparticles  Schwann cells  
Construct containing 2.5 wt% of PAG revealed to be the most suitable in terms of 
Schwann cell adhesion 
Baniasadi et al., 2016 
[133] 
Graphene-based eletrode MSCs 
Differentiation of MSCs into Schwann cell-like phenotypes through an electrical 
stimulus, without the need of additional chemical growth factors  
Das et al., 2017 [134] 
Polypyrrole functionalized graphene 
(PPy-Graphene) 
Retinal ganglion cells  
PPy-Graphene based aligned nanofibers were fabricated for guided growth and 
electrical stimulation of RGCs. Significantly enhanced viability, neurite outgrowth 
and anti-aging ability of RGCs were observed after electrical stimulation 
 
Zhao et al., 2016 
[135] 
GO-coated PLLA electrospun nanofibers  
Schwann cells, PC12 cells  
 
The GO coating improved properties of the simply aligned PLLA nanofibrous mesh, 
including surface roughness and hydrophilicity. Also, it significantly promoted SCs 
growth and regulated cell orientation, and induced PC12 cells differentiation and 
neurite growth 
 
Zhang et al., 2016 
[136] 
Electrospun graphene-silk fibroin 
composite 
L929 cells, Schwann cells  
10% of graphene in the nanofibrous mesh was selected as the optimized one, as this 
specific concentration allowed cell viability and cell attachment 
 
Zhao et al., 2017 
[137] 
Electrospun silk fibroin scaffolds coated 
with reduced GO 
PC12 cells 
The coating with GO improved the adhesion of cells. The use of SF/GO scaffolds 
combined with electrical stimulation promoted the differentiation into neural 
phenotypes more than treatment with NGF 
Aznar-Cervantes et 
al., 2017 [138] 
Hybrid Gr nanosheets-sodium alginate 
(SA)/polyvinyl alcohol (PVA) (Gr-AP) 
fibrous scaffold 
PC12 cells 
Successfully developed hybrid graphene incorporated alginate/PVA fibrous scaffolds 
in which the best amount of graphene was 1 wt% 
Golafshan et al., 2017 
[139] 
 
Graphene oxidized combining with 
decellularized rat sciatic nerve defect 
(allograft) 
Rat sciatic nerve defect 
GO nanomaterial could combine with allogeneic sciatic nerve decellularized scaffold 
to facilitate nerve regeneration 
Wang et al., 2017 
[140] 
Graphene oxide foam layers with 
thicknesses of ∼15–50 μm 
hNSCs 
Rolled GOFs were developed as electrically conductive 3D-scaffolds with desirable 
large-scales and utilized in directional growth of neural fibers under electrical 
stimulations 
Akhavan et al., 2016 
[141] 
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poly(ε-caprolactone) tubular prosthesis 
associated with nanoparticles of carbon 
and graphene 
Rat sciatic nerve defect Nanocomposite PCL tube enables nerve repair and results in better regeneration  
Assaf et al., 2017 
[142] 
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construct containing 2.5 wt% of PA-Graphene revealed to be the most suitable in terms 
of SCs adhesion, and therefore the most promising for PNR. 
Das et al., [134] reported for the first time a method that allows the differentiation of 
mesenchymal stem cells (MSCs) into a SC-like phenotype through electrical stimuli, 
without the need of additional chemical growth factors. Such differentiation was carried 
out on a flexible, inkjet-printed graphene interdigitated electrode. This work opened 
doors to the scalable nano-manufacturing of graphene and graphene-based circuits with 
complex geometries on virtually any substrate, including flexible and degradable 
polymers.  
Nanofibers are considered a very promising type of scaffold for the integration of 
graphene. Zhao et al., [135] synthesized polypyrrole functionalized graphene (PPy-
Graphene) by using for the first time a simplistic but effective polymerization-enhanced 
ball milling method, which is an environmental-friendly, easy to be controlled and 
efficient method for preparing functionalized graphene. Such strategy can be envisioned 
for application as a retinal electronic implant to repair the damage of optic nerve, which 
is mainly derived from the atrophy, apoptosis or death of retinal ganglion cells (RGCs). 
Following the polymerization reaction, PPy-Graphene based aligned nanofibers were 
fabricated and designed to act as guiding cues and permit electrical stimulation of 
RGCs. This successful approach significantly enhanced viability, neurite outgrowth and 
anti-aging ability of RGCs after electrical stimulation.  
Zhang et al., [136] also fabricated GO nanosheets with topological structure of aligned 
nanofibrous for PNR applications. However, these differ from the above since the GO 
nanosheets were coated onto aligned and aminolyzed poly-L-lactide (PLLA) 
nanofibrous scaffolds produced by electrospinning. The GO coating improved several 
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properties of the simply aligned PLLA nanofibrous mesh, including surface roughness 
and hydrophilicity. Further than that, it significantly promoted SCs growth, regulated 
cell orientation and induced PC12 cells differentiation and neurite growth.  
Zhao et al., [137] were able to obtain graphene/silk fibroin (SF) based nano-membranes 
acquired by electrospinning technique. Graphene percentage varied from 0% to 20%, 
however a concentration of 10% of graphene in the nanofibrous mesh was selected, 
since it allowed cell viability and attachment, supporting the survival and growth of SCs 
with no significant cytotoxic effects. 
In a similar approach, Aznar-Cervantes et al., [138] reported promising results that 
indicate the potential use of electrospun SF scaffolds coated with reduced GO for neural 
tissue engineering. The stimulus provided by the reduced GO alone induced a 
significant differentiation level of PC12 cells to neuronal-like phenotype, which can 
even increase by application of electrical stimulation. By this manner, the neurite 
outgrowth was more pronounced when electric currents are applied to the cell cultures 
when compared to the traditional treatment with nerve growth factor (NGF). 
Golafshan et al., [139] developed hybrid graphene incorporated alginate/PVA fibrous 
scaffolds with varying amounts of graphene (up to 5 wt%), using an electrospinning 
approach for engineering nerve tissue. The authors found that the incorporation of 
1 wt% of graphene in the nanosheets enhanced the toughness and strength of the 
scaffolds by 4- and 3-fold, while tensile modulus did not significantly vary. Moreover, 
the addition of graphene upon 1 wt% resulted in a significant reduction in impedance 
value, meaning higher electrical conductivity, which is advantageous for PNR. 
Wang et al., [140] innovatively prepared GO through improving Hammer’s Method and 
combining it with decellularized scaffold of a sciatic nerve of rats. The 
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GO/decellularized scaffold was used to bridge a 10 mm gap of injured sciatic nerve. 
Such operation was conducted by using the oscillation mixing method. It has been 
proved that GO nanomaterial could be associated with allogeneic sciatic nerve 
decellularized scaffold to induce nerve regeneration. The regeneration parameters 
evaluated, i.e. sciatic nerve action potentials, thickness of myelin sheath, diameter of 
axon and dominated muscle rehabilitation level, revealed that the regeneration of the 
nanomaterial group were significantly higher than the blank group. 
Graphene foams have successfully been developed and suggested as 3D scaffolds 
providing an adequate support with the desired topographies for differentiation of cells 
[143]. Akhavan and colleagues, [141] firstly fabricated graphene oxide foam (GOF) 
layers with thicknesses of ∼15–50 μm and density of ∼10 graphene oxide. Then, the 
GOF layers with desirable scales were rolled to obtain 3D scaffolds with capability of 
inducing directional proliferation and differentiation of neurons along the main axis of 
the rolls. After seeding human neural stem cells (hNSCs) and proceeding with electrical 
stimulation, increased hNSCs proliferation rates and accelerated differentiation into 
neurons was observed, as compared to the differentiation into glial cells. 
Assaf et al., [142] combined both graphene and carbon NPs to enhance the properties of 
a tubular conduit made of PCL. Despite the final conduit transparency and adequate 
mechanical properties, which allowed the correct alignment of the stumps, the gap was 
not a critical gap presenting only 3 to 4 mm between the nerve ends, therefore not 
permitting a correct evaluation of the results. 
3.1.3. Carbon nanofibers 
Carbon nanofibers (CNFs) are other type of carbon nanomaterials, such as vapor grown 
carbon nanofibers [144] and carbonization of polymer-based nanofibers produced in the 
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electrospinning process [145] that are manufactured using different methods. These 
nanofibers are characterized as non-microporous graphitic materials with a high surface 
area (100–200 m2/g), high purity and tunable surface chemistry [146]. They have been 
investigated for numerous applications due to their unique physical properties, such as 
high strength, low density, metallic conductivity, tunable morphology, chemical and 
environmental stabilities, as well as compatibility with organo-chemical modification 
[147]. 
Being the less explored carbon nanomaterials, especially for PNR applications, CNFs 
were developed by Shilpee and colleagues, [148] using electrospinning technique. Their 
effect on SCs fate was studied when seeded on amorphous carbon substrates, depending 
on the evolution of intracellular oxidative stress. That results are encouraging, as 
evidenced that CNFs own a conducting nature and their fibrous structure can provide 
directional growth to axons, facilitating SCs proliferation and growth. The level of 
reactive oxygen species was not high enough to induce apoptosis in all the culturing 
periods tested on carbon fibrous and film substrates. 
Wei Zhu et al., [149] developed novel carbon nanofibrous scaffolds by annealing 
electrospun mats at elevated temperature, whose graphitic structure generated by 
annealing rendered superior electrical conductivity. When subjected to electrical 
stimulation, neural stem cell proliferation was promoted, while an up-
regulated neuronal gene expression level and increased expression of microtubule-
associated protein 2 were detected, thus demonstrating an improved neuronal 
differentiation and maturation. 
3.1.4. Nanodiamonds 
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Nanodiamonds (NDs) were termed for the first time by researchers in World War II in 
1963, as detonation investigations with carbon-based explosives were being 
implemented and 4-5 nm diamond particles accompanied by graphite and other non-
diamond carbon particles were found [150]. 
NDs are an evolving type of carbon nanomaterials which holds a distinctive set of 
properties, either at a chemical, physical, and biological level. Its generic structure can 
be appreciated in Figure 4AII. Above all, they are considered to be completely non-
toxic, making them suitable for biomedical applications [151]. Such intrinsic 
physicochemical properties are indispensable and allow designing innovative therapies 
in several areas of the medical field, such as delivery of therapeutic molecules, and 
many applications in TE and imaging [152]. 
In what concerns drug delivery, NDs are promising materials because of their high 
surface area to volume ratio and surface chemistry, which permits the stocking of 
molecules in their amine groups, as well as in other polar moieties. The phenomenon 
occurs by physical adsorption, allowing drugs and other molecules of interest to be non-
covalently linked to NDs [151]. This simplistic loading process is effective and does not 
involve the usually hard and time-consuming processes of chemical modification [153]. 
Another major advantage of NDs is that they are promptly internalized by cells but do 
not undergo an immediate exocytosis. Therefore, bioactive molecules stay within the 
cell for an improved therapeutic effect [154]. 
Similarly to other carbon nanomaterials, NDs have also been used as nano-fillers to 
strengthen the mechanical properties of composite implantable biomaterials.  
The number of advantages of NDs increased, as the optical properties of fluorescent 
NDs (FNDs) allowed their use as imaging probes. Importantly, the FNDs were able to 
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retain high photostability and longer fluorescent periods as compared to other 
fluorophores used in cellular imaging [155]. These properties permit the location of 
such NPs within living organisms. 
Finally, the high biocompatibility of NDs when compared to the above-mentioned 
carbon nanomaterials (e.g., SWCNTs, MWCNTs, graphene), translates into a great 
advantage for NDs and increases the probability of such carbon materials to be 
translated to the clinical practice [156]. Although NDs’ mechanical and electrical 
properties seem suitable for PNR applications, there are not many works publications 
describing the use of this promising technology. These properties combined with the 
aforementioned ones, make NDs an encouraging environment for neuronal networks. 
Table 5 summarizes the most relevant reports describing the use of NDs in PNR [157-
162]. 
Interestingly, Thalhammer et al., [163] first tested a NDs monolayer coating surface to 
promote the formation of functional neuronal networks, achieving extraordinary results 
that proved that detonation-derived NDs exhibit encouraging similarity to protein-
coated materials in what concerns neuronal cell attachment, neurite outgrowth and 
functional network formation. Furthermore, cell-autonomous neuronal excitability and 
functionality of the resulting electrical networks demonstrated the potentiality of this 
type of coating. 
More recently, Hopper et al., [157] were able to produce amine functionalized NDs, 
which were studied as substrates for neuronal cell culture. The obtained results 
indicated that these functionalized NDs are beneficial for in vitro neural cell culture and 
can be regarded as possible coatings for in vivo neural implants. The NDs were able to 
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support the growth of primary SCs and DRGs neurons with the correct phenotype over 
three weeks of in vitro culturing. 
In the same year, Huang et al., [158] reported for the first time the influence and 
application of FNDs on the nervous system. Neurons were treated with FNDs particles, 
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Table 5 - The use of nanodiamonds applied to peripheral nerve regeneration. 
Type of nanodiamonds Cell type or animal model Main results References 
Amine functionalized 
ND 
NG108-15 neuroblastoma cells, SCs, DRGs 
 
Amine-terminated surface NDs proved to be a suitable substrate since 
it promoted neuronal cell adhesion, proliferation and neurite 
outgrowth 
 
Hopper et al., 2014 [157] 
Fluorescent ND Hippocampal neurons and DRGs 
Fluorescent ND did not induce cytotoxicity in primary neurons from 
CNS or PNS. However, interfere with neuronal morphogenesis  
 
Huang et al., 2014 [158] 
ND ink Not applicable 
ND solutions can be used instead of proteins and factors that are 
commonly used for cell guiding patterning 
 
Tong et al., 2015 [159] 
3D-nanostructured boron 
doped ND 
Spinal cord and hippocampal cell cultures  
 
3D-nanostructured BDD offers good performances for neural 
recording and stimulation 
 
Piret et al., 2015 [160] 
Nitrogen included ultra 
nanocrystalline diamond 
Rat cortical neurons  
The fabricated neural interfaces exhibit high efficacy, long-term 
stability and a healthy neuron/electrode interface 
 
Tong et al., 2016 [161] 
 
Micro-textured 
nanocrystalline diamond 
Inner-ear neuron of human and mouse origins 
and ReNcell (a human neural progenitor 
cell line) 
The findings demonstrate that regenerating auditory neurons show a 
strong affinity to the NCD pillars, and the technique could be used 
for neural guidance and the creation of new neural networks  
Cai et al., 2016 [162] 
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which did not induce cytotoxicity in primary neurons from either CNS or PNS. 
Furthermore, the neuronal uptake of FNDs was confirmed, as seen in Figure 4D. 
Nevertheless, it was found that FNDs caused a decrease in neurite length in both CNS 
and PNS neurons. These outcomes proved that FNDs exhibit low neuronal toxicity but 
in fact, have the power to interfere with neuronal morphogenesis. This must be 
considered when the application of FNDs involves the growing of neurites, such as in 
PNR.  
In a different approach, Tong et al., [159] presented a method for fabricating a diamond 
platform with the goal to direct neural cell adhesion. Micro-contact printing was used 
for selective NDs seeding and chemical vapor deposition was conducted subsequently 
to form NDs patterns. As a result of this work, it was observed that NDs solutions can 
be used in replacement of proteins and factors that are commonly used for cell 
patterning with good alignment results. 
In the field of neural implants and neuroprostheses, Piret et al., [160] aimed at 
developing a platform that exhibits high capacitance and appropriately contacts with 
neurons to provoke real neural responses at low voltages. For such, they developed a 
3D-nanostructured boron doped NDs platform. This interface allowed neural cell 
attachment, survival and neurite extension, after experiments with spinal cord and 
hippocampal cell cultures. Particularly, the platform allowed the detection of low 
amplitude in the range of 10–20 μV local-field potentials. These properties are found to 
be extremely valuable for the fabrication of diamond neural interfaces with the 
predictable long-term steadiness of diamonds at the same time supporting the life of 
healthy neurons. 
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In the same field, Tong et al., [161] reported on a new high capacitance material 
fabricated using nitrogen - ultra nanocrystalline diamond (N-UNCD), which was treated 
with oxygen plasma, resulting in increased charge injection capacity. Rat cortical 
neurons were used in vitro to measure its biocompatibility. Surface roughness was 
found to be critical for healthy neuron growth, with best results observed on surfaces 
with a roughness of approximately 20 nm. Overall, the authors provided a method of 
producing a ND electrode that is optimized for both high charge injection capacity and 
neuronal biocompatibility. 
In the field of cochlear implants for patients with profound hearing loss due to neuronal 
deficits, Cai et al., [162] developed micro-textured nanocrystalline diamond (NCD) 
surfaces on cochlear implants electrode arrays, where the surface consisted in 
micrometer-sized pillars (size 5 × 5 μm2). When using human and murine inner-ear 
ganglion neurites and a neural progenitor cell line, the results showed that these cells 
can attach to patterned NCD surfaces without any ECM coating. These findings 
demonstrated that regenerating auditory neurons have a solid affinity to the NCD pillars 
and the technique could be used for neural guidance and the creation of new neural 
networks. 
3.1.5.  Carbon nanomaterials toxicity  
Although the popularity of carbon nanomaterials has been increasing due to their high 
biocompatibility and consequent potential in the area of biomedicine (e.g. drug delivery, 
bio imaging and tissue engineering), its likely cytotoxicity has raised some concerns 
[164]. Because of their unique and innovative physico-chemical characteristics explored 
previously, an intensive use of such NP is expected, resulting in the accumulation of 
carbon molecules in the environment.  
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Currently, one of the main alarms of the utilization of carbon nanomaterials falls in the 
scope of toxic effects on reproductive system. For instance, GO has shown potential 
side effects on both females and their offspring. The results obtained give evidence to 
extremely high toxic effect of GO on females at late pregnancy stages [165].  
Regarding SWCNT, this nanomaterial has shown side effects at both low high 
concentrations: when administered at high concentrations, the number of miscarriages 
was significantly augmented. Groups exposed to small dosage had apparent defects of 
embryonic development [166].  
When dealing with MWCNT, many studies focusing on mammal’s embryonic 
development [167], delay of pregnancy time, offspring’s quality [168] and even male 
reproductive system [169], no significant anomalies had been detected. 
Pulmonary toxicity has also been demonstrated for this type of materials. Several 
processes of toxicity include inflammation [170], injury [171], fibrosis [172] and 
pulmonary tumor [173].  
Although the previous studies provide valuable insights into the toxicity of carbon 
materials at different levels, there is still a lack of reproducible and accurate results that 
can be used to make a final statement on their use and safety. Although red flags arise 
when toxicity is found in rodent models, studies need to be correctly designed in order 
to assess the risk of exposure for nature and human health.  
3.2. Nanoparticles  
In the last years, researchers have been proposing the use of NPs for neural regeneration 
approaches [174]. There are several benefits offered by NPs, such as their small size, 
physical properties that diverge from the bulk, surface functionalization and chemical 
stability. They also differ from other nano-sized particles in their electrical charge, 
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magnetic and optical properties [175]. These nano-sized biomaterials are mainly 
envisioned as carriers for targeted and controlled delivery of drugs and other biological 
molecules such as growth factors, both in vitro and in vivo. Antibodies, labeling probes, 
hydrophobic or hydrophilic molecules, DNA and oligonucleotides are other types of 
molecules that can be linked to NPs, allowing a tailored application for the desired 
purpose, such as drug delivery or cell tracking and monitoring [176, 177]. This 
versatility is mostly a result of the wide range of approaches that can be used for NPs 
functionalization. Furthermore, NPs are widely used to enhance the properties of 
scaffolds, as mechanical properties and degradation rate in several TE applications.  
When it concerns to neuronal regeneration, NPs can be used with different purposes, as 
enhancing neuronal differentiation [178], stimulating neuronal regeneration and survival 
[179], manipulation of neuronal electrical activity [180, 181] or allowing imaging and 
theranostics [182]. NPs will be divided according to their composition in two main 
categories, inorganic and organic, and the most significant reports overviewed herein.  
3.2.1. Inorganic NPs  
Inorganic nanomaterials are being widely exploited for nerve regeneration applications. 
Within this field, gold (Au), zinc (Zn), silver (Ag) and silica-based NPs (SiO2-NPs) are 
the ones that have been attracting a great deal of attention. Table 6 summarizes the most 
significant works describing the use of inorganic NPs applied in PNR [179, 183-186, 
188-204, 208]. 
3.2.1.1.  Magnetic NPs 
Magnetic elements in the nanometer scale (e.g. iron, nickel, cobalt and their oxides), are 
being used in different biomedical applications [205]. One characteristic that is 
modified when iron becomes a nano-scale material is its magnetism. Reducing the size 
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of iron as a bulk material to the nano-scale level results in superparamagnetic behavior. 
Superparamagnetic iron NPs (SPIONs) are non-magnetic particles until they are 
exposed to a strong magnetic ﬁeld. If the magnetic ﬁeld is removed, they revert to a 
non-magnetic state again [187]. Several approaches have been using these magnetic 
NPs (MNPs) in the 
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Table 6 - The use of inorganic nanoparticles applied to peripheral nerve regeneration. 
 Type of nanoparticle Cell type or animal model Main results References 
Magnetic 
NPs 
PEI-coated Fe3O4 NP 
 
PC12 differentiation 
MNPs direct the neurite outgrowth preferentially 
along the direction imposed by an external magnetic 
field 
 
Riggio et al., 2014 [183] 
Maghemite (γ-Fe2O3) fluorinated magnetic 
NP and Magnetite (Fe304) core particles 
with different coatings 
PC12 cells and SHSY-5Y 
cells 
 
MNPs control neurite growth orientation of primary 
neurons along the process of neural network 
formation 
 
Marcus et al., 2016 [184] 
SPIONs SCs and astrocytes 
SPION-mediated forces could act as powerful 
stimulants to enhance the migration of SCs across the 
astrocyte-SC boundary 
 
Huang et al., 2017 [185] 
 
MNP (Fe3O4)–chitosan mixture was 
fabricated into membranes or scaffolds  
SCs 
Magnetic nanocomposites containing 10% MNPs 
were able to support SCs adhesion and spreading 
under magnetic field exposure. Same concentration 
of MNPs, increased the gene expression and protein 
secretion of BDNF, GDNF, NT-3, and VEGF 
 
Liu et al., 2014 [186] 
MNP (Fe3O4)–chitosan scaffold (same 
author as previous) 
SCs; rat sciatic nerve defect 
The magnetic chitosan scaffold synergized with the 
magnetic field enhanced the viability of SCs. The 
same scaffold loaded with SCs in addition to the 
magnetic field promoted nerve regeneration and 
functional recovery 
Liu et al., 2017 [208] 
SPIONs 
MSCs single cells or 
spheroids; rat sciatic nerve 
defect 
Compared to MSC single cells, the pristine or BDNF-
transfected MSC spheroids significantly promoted 
the functional recovery of animals  
 
Tseng et al., 2014 [188] 
 
Nanohydroxyapatite (n-HA) coated Fe3O4 
magnetic NP 
DRGs 
(n-HA) coated Fe3O4 can successfully increase cell 
viability and promote axonal elongation. Also, 
Netrin-1 axonal guidance cues rise significantly after 
treatment with n-HA-coated Fe3O4 
 
Liu et al., 2015 [189] 
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Polyethylenimine -coated (Fe3O4)NPs 
PC12; zebrafish; rat sciatic 
nerve defect 
MNPs functionalized with NGF and VEGF 
accelerated the regeneration process and recovery of 
motor function 
 
Giannaccini et al., 2016 
[190] 
SPIONs DRGs 
NGF releasing PLLA/iron oxide composite-NPs can 
direct neurite outgrowth and composite-NPs can be 
positioned by external magnetic ﬁeld gradients  
 
Zuidema et al., 2015 [191] 
SPIONs L929, DRGs 
With the aid of SPIONs and a magnetic field, the 
micro-structure of an hydrogel could be aligned, 
which in turn aligned the neurites of the DRSs  
Rose et al., 2017 [192] 
Metallic NPs 
Gold nanorods NG108-15 neuronal cells 
NG108-15 cells were cultured with both bare and 
coated Au NRs and then irradiated with 1.2-
7.5 W/cm(2) at 780 nm, which showed a neurite 
length increase of up to 25 µm versus control 
Paviolo et al., 2013 [193] 
Gold nanorods NG108-15 neuronal cells 
When NG108-15 neuronal cells were exposed to the 
NIR light of 780 nm laser diode, it was  found to 
induce intracellular Ca
2+
 transients 
Paviolo et al., 2014 [194] 
Polyethylenimine -coated gold-NPs PC12 cells 
Pulsed current stimulation induced neurite outgrowth 
of PC12 cells to the AuNPs coated surfaces, thus 
proving the potential of AuNPs as an electrically 
conductive matrix for nerve regeneration 
Adel et al., 2017 [195] 
Gold-NP adsorbed in electrospun silk 
fibroin nanofibers 
SCs; rat sciatic nerve injury 
AuNP-silk fibroin nanofiber noticeably decreases the 
resistance of an electrically insulating material like 
silk 
Das et al., 2015 [196] 
AuNPs modified with 6-mercaptopurine 
(6MP) and a neuron-penetrating peptide  
SH-SY5Y cells 
Seeded SH-SY5Y cells in a surface coated with 6MP-
AuNPs-RDP, are capable of internalizing NP, which 
led to a significant increase of neurite growth 
Xiao et al., 2017 [197] 
Gold nanoparticles/Polyvinylidenefluoride 
(PVDF) composite electrospun mat 
PC12 cells 
Au NPs/PVDF composite nanofibers have the ability 
to stimulate the growth and adhesion of neuronal 
cells 
Motamedi et al., 2017 [198] 
Chitosan-zinc oxide nanocomposite 
conduit 
Rat sciatic nerve defect 
Chitosan-zinc oxide nanocomposite conduit resulted 
in acceleration of functional recovery and 
Iman et al, 2017 [199] 
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quantitative morphometric indices of sciatic nerve  
PCL electrospun matrix with variable 
quantities of zero valent zinc NPs 
Human primary ﬁbroblasts 
and U87 brain glioblastoma 
cell line 
Low concentrations of Zn-NPs promoted neuronal 
regeneration and showed relatively non-toxic 
characteristics to fibroblasts  
Aydemir et al., 2017 [200] 
Silver NPs SH-SY5Y cells 
The analysis of single neurite level reveals increased 
neurite formation and growth, better than on the 
AuNP and ZnONP substrates or smooth substrates  
Alon et al., 2014 [179] 
Silica NPs 
SiO2-NPs Guinea pigs 
Significantly greater survival of SGNs in cochleae 
that received BDNF. Supraparticles were well 
tolerated  
Wise et al., 2016 [201] 
SiO2-NPs encapsulated within a lipid 
bilayer and modified with the atoxic 
subunit B of the cholera toxin (CTB) 
Motoneuron-like NSC-34 
cells and L6 muscle cells  
SiO2-NPs functionalized with CTB showed greater 
motor neuron uptake when compared to unmodified 
lipid bilayer (60% vs. 15%, respectively) 
Porras et al., 2016 [202] 
Aligned poly lactic- PLGA and 
PLGA/gelatin nanofibrous scaffolds 
embedded with mesoporous SiO2-NPs 
PC12 
Cellular proliferation on PLGA and PLGA/gelatin 
with SiO2-NPs were higher than that on the aligned 
pure PLGA scaffolds 
 
Mehrasa et al., 2015 [203] 
SiO2-NPs encapsulated with Tetrodoxin Rat sciatic nerve defect 
The proved sustained release properties of hollow 
SiO2-NPs contributed to the extension of nerve block 
and enhanced safety by slowing release 
Liu et al., 2017 [204] 
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last few years [206, 207]. The main advantages rely on the fact that MNPs-loaded cells 
can be directed to specific sites in response to an external magnetic field gradient and 
the possibility of imaging through MRI. Figure 5 captures some of the most interesting 
results related to the use of MNPs applied to PNR. 
 
Figure 5 
In 2014, Riggio et al., [183] developed and validated a non-invasive approach for 
physical guidance of nerve regeneration based on the synergic use of MNPs allied to the 
appliance of magnetic fields. For such, in situ polymer coating was done with 
polyethylenimine of iron oxide MNPs, which were further functionalized with NGF. 
These MNPs demonstrated to be able to trigger PC12 differentiation into a neuronal 
phenotype. Above all, these authors evidenced that mechanical tension created by the 
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MNPs and the magnetic field can induce “stretch growth” of neurites process initiation, 
as depicted in Figure 5A.  
Marcus et al., [184] studied the interactions of four different types of iron oxide MNPs 
with PC12 cells and have shown that cell uptake is highly sensitive to the MNPs type 
and incubation conditions. The researchers demonstrated that uncoated maghemite 
MNPs led to maximal cellular penetration, thus proposing these particles as efficient 
candidates for magnetic-based neuronal manipulations. Once again, MNPs were 
demonstrated to be effective in controlling neurite growth orientation of primary 
neurons along the process of neural network formation using a magnetic field. 
Huang et al., [185] developed a way to improve the therapeutic potential of SCs, which 
consisted in magnetically drive SCs to migrate across the astrocyte-SC boundary to 
interact with astrocytes (Figure 5B). To achieve that, SCs were firstly magnetized with 
PLL-coated SPIONs. As a result, magnetized SCs exhibited enhanced migration along 
the direction of force in the presence of a magnetic field. It was also demonstrated that 
SPION-mediated forces could act as powerful stimulants to enhance the migration of 
SCs across the astrocyte-SC boundary, via integrin-mediated mechano-transduction. 
Using the same kind of strategy of combining magnetically responsive MNPs and a 
magnetic field, Liu et al., [186] prepared MNPs–Cht/glycerophosphate membranes and 
scaffolds and explored whether such magnetic nanocomposites would regulate SCs 
biological activities via application of magnetic fields. It was observed that magnetic 
nanocomposites containing 10% MNPs were able to support cell adhesion and 
spreading and further promote proliferation of SCs under magnetic field exposure. 
Interestingly, a magnetic field applied through the 10% MNPs scaffold significantly 
increased the gene expression and protein secretion of brain-derived neurotrophic factor 
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(BDNF), glial derived neurotrophic factor (GDNF), neurotrophin-3 (NT-3) and VEGF. 
Later on, the same authors proved that the same scaffolds had modest magnetization and 
proper degradation rate, making them suitable for cellular distribution and new axon 
regeneration [208]. After loading the scaffold with SCs and exposure to a magnetic 
field, it was observed a synergistic improvement of nerve regeneration and functional 
recovery in vivo, by increasing the distribution efficiency and viability of SCs. 
Tseng et al., [188] combined the cell transplantation strategy with the use of spheroids 
and the incorporation of SPIONs. The authors investigated the effect of the substrate-
derived MSC spheroids versus single cells on the regeneration of transected rat sciatic 
nerve (Figure 5D). This effect was evaluated after injection of Fe3O4NPs-labeled MSC 
spheroids into microporous nerve conduits made of polylactide acid (PLA). With this 
strategy, MRI could be employed to trace the distribution and migration of these 
spheroids in vivo. Furthermore, authors also delivered BDNF gene to MSC spheroids 
and evaluated the efficacy of BDNF-transfected spheroids on nerve regeneration across 
the gap defect, which showed significant functional recovery.   
Liu et el., [189] explored for the first time the use of hydroxyapatite-coated MNPs to 
enhance neuronal regeneration in injured nerves. For that purpose, the experiments were 
carried out on cultured rat DRG neurons and the results showed that n-HA-
coated magnetic NPs (Fe3O4
+n-HA) can effectively increase cell viability and promote 
axonal elongation. Interestingly, the authors have also demonstrated by Western blot 
that Netrin-1 axonal guidance cues significantly increase after n-HA-
coated magnetic NPs treatment. 
Gianaccini et al., [190] reported on the ability to immobilize NGF and VEGF on MNPs 
for controlled release, both in vitro and in vivo. Bioactivity tests were performed to 
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induce a neuronal-like phenotype in PC12 cells with NGF and neo-angiogenesis in a 
zebrafish model with VEGF. Afterwards, a neurotmesis of the rat median nerve was 
made in which the two nerve stumps were sutured to the ends of a synthetic conduit 
filled with the particles. In conclusion, there was an increase in the stability of growth 
factor concentration and delivery, mediated by MNPs. Its use is responsible for the 
enhanced neuroprotective effects of VEGF and NGF in the MNPs group as compared 
with the control group. 
Zuidema et al., [191] established a composite-NPs to create NGF gradients at speciﬁc 
locations within a tissue culture dish to direct neurite extension. The composite 
nanoparticle was fabricated by combining NGF-releasing PLLA NPs with iron oxide 
MNPs, which were manipulated by the administration of an external magnetic ﬁeld 
gradient, through the modiﬁcation of water/oil/water double emulsion technique. NGF-
composite-NPs was afterwards combined with aligned PLLA microﬁbers to create a 
biomaterial approach that utilizes both topography and chemotropic gradients to direct 
extending neurites. In brief, the authors have demonstrated that magnetic, NGF 
releasing PLLA/iron oxide composite-NPs can direct neurite outgrowth and that 
composite-NPs can be positioned by external magnetic ﬁeld gradients, and release NGF 
for up to 6 days. This can be seen in Figure 5C. 
Also in combination with other materials, namely injectable hydrogels, Rose et al., 
[192] developed the ﬁrst biomaterial that can achieve in situ highly controlled and 
ordered structures after injection to guide cell and nerve growth. Those are 
magnetoceptive, anisometric microgels that were applied as building blocks to create a 
unidirectional structure, with the aid of magnetic fields. For such, microgels were doped 
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with small quantities of SPIONs, allowing alignment by external magnetic fields in the 
milliTesla order, in which DRGs neurites were stimulated, to grow and align. 
3.2.1.2. Other metallic NPs 
Metallic NPs are predominantly striking because of their unique optical properties. 
Indeed, when metal NPs are irradiated by an external light field, they can generate a 
resonant coherent oscillation called “localized surface plasmon resonance”, which 
depends on the NPs shape and aspect ratio [209].  
With respect to metallic NPs, gold NPs (AuNPs) and gold nanorods (AuNRs) are the 
most widely explored. The integration of AuNPs in neurological research has the 
potential to lead to the discovery of new approaches to treat conditions that medicine 
and science previously failed to. This perspective arises from their exceptional 
properties, including optical response, chemical and physical stability, relatively low 
toxicity, and wide range of possible surface functionalization [210]. 
Paviolo and colleagues, [193] revealed a novel and extraordinary application for AuNRs 
associated with a low power laser exposure of NG108-15 neuronal cells after uptake of 
such NPs. Surprisingly, when these cells were irradiated with a 780 nm laser (IR or 
near-IR), the number of neurons and respective neurites augmented. A scheme of such 
work can be observed in Figure 6A. Later on, the same authors [194] explored one of 
the mechanisms of such phenomenon. They described the fabrication of AuNRs that 
were up-taken by NG108-15 neuronal cells. Cells were then exposed to the near-
infrared (NIR) light of 780 nm laser diode, which was found to induce intracellular Ca2+ 
transients. In order to explain such phenomena, the authors hypothesized that the 
temporary heating resultant from the light excitation of the localized Surface Plasmon 
Resonance (SPR) of the NRs could serve either to generate changes in the cellular 
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membranes capacitance by activating temperature sensitive ion channels in the cell 
membrane or to diminish the intracellular calcium storage in the organelles.  
 
 
Figure 6 
In a study reported by Adel et al., [195] AuNPs were able to induce neurite outgrowth 
of PC12 cells, after another kind of stimulus to which these particles are sensitive to:  
pulsed electrical stimulation. The authors firstly evaluate the deposition of 39 nm 
AuNPs onto polyethyleneimine pre-coated surfaces and then studied the effect of the 
pulsed electrical stimulation. That study showed that pulsed current stimulation induced 
neurite outgrowth of PC12 cells adhered to the AuNPs coated surfaces, thus 
demonstrating the potential use of AuNPs as electrically conductive matrix for nerve 
regeneration. 
Being aware that the presence of AuNPs enhances the conductive potential of the 
materials, Das et al., [196] reported on a novel SF-Au nanocomposite conduit which 
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was tested in a neurotmesis grade sciatic nerve injury rat model over a period of 
eighteen months, after pre-seeded with rat SCs. To produce this scaffold, AuNPs were 
adsorbed onto silk fibers and further transformed into a nanocomposite sheet by 
electrospinning. The results show that AuNPs-SF nanofiber noticeably decreases the 
resistance of an electrically insulating material like silk. 
Xiao et al., [197] reported on the production of AuNPs modified with 6-mercaptopurine 
(6MP) and a neuron-penetrating peptide (RDP) as a neurotrophic agent. The 6MP is an 
anti-inflammatory drug which has been used to functionalize the surface of AuNPs to 
form 6MP-modified AuNPs (6MP-AuNPs) through an Au-sulfur bond. Additionally, 
with the purpose of increasing the neural cell uptake efficiency of 6MP-AuNPs, the 
RDP was linked to the particle surface to form a 6MP-AuNPs-RDP conjugate. When 
SH-SY5Y cells were transplanted to a surface coated with 6MP-AuNPs-RDP it was 
concluded that the conjugate attached to the cell surface and was then internalized into 
cells, which in turn led to a significant increase of neurite growth. 
Motamedi et al., [198] fabricated and characterized AuNPs/polyvinylidenefluoride 
(PVDF) composite electrospun mat with enhanced piezoelectricity in which the Au 
colloidal NPs were prepared via laser ablation of metallic targets in liquid media. After 
an extensive physicochemical characterization, the in vitro cytocompatibility, as well as 
the attachment and morphology of PC12 cells cultured on the electrospun composite 
was evaluated. It was demonstrated that laser ablated AuNPs can be used together with 
PVDF nanofibers, with proper organizational properties and increased piezoelectricity.      
Zn is another metal that can be conjugated with NPs to form electrically conductive 
matrices. Having in mind that numerous studies have reported that the mechanical and 
electrical properties of different polymers have improved when Zn oxide NPs are 
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incorporated into polymeric matrices, Iman et al., [199] reported the fabrication of a 
Cht-Zn oxide nanocomposite conduit and its effect on functional recovery of transected 
PNs. Results of this study indicated that the use of a Cht-Zn oxide nanocomposite seems 
to have several distinct advantages for the treatment of PNs, because it is inert and does 
not induce extensive scarring or degeneration after implantation. Also, Aydemir Sezer 
and colleagues [200] attempted to use for the first time a PCL electrospun matrix with 
variable quantities of zero valent ZnNPs, aiming at using it as conductive and 
biodegradable luminal fillers. Human primary ﬁbroblasts and U87 brain glioblastoma 
cell line were used for evaluation of cytotoxicity, metabolic activity and proliferation. 
The results showed that low concentrations (5 and 10%) of ZnNPs were non-toxic to 
fibroblasts and promoted neuronal regeneration. The fact that electrical conductance 
became approximately nine times greater in PCL/Zn5 samples than in PCL, and 
material characterization and mechanical analysis indicated that the material is 
compatible with soft tissues and is suturable, makes it a great candidate for PNR 
applications. 
Alon et al., [179] reported the use of AgNPs as regenerative agents to promote neuronal 
growth. Neuroblastoma cells were seeded on surfaces coated with AgNPs. The effect on 
the development of the neurites during the initiation and the elongation growth phases 
was evaluated, with the observation that AgNPs function as favorable anchoring sites. 
Indeed, the growth on the AgNPs-coated substrates leads to a significantly enhanced 
neurite outgrowth with three times more neurites than cells grown on uncoated 
substrates, and two times more than cells grown on substrates sputtered with a plain 
homogenous layer of Ag, which thus evidences the benefit of using AgNPs. 
3.2.1.3. Silica NPs 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
63 
 
Moreover, still in the scope of inorganic NPs, SiO2-NPs play an important role. SiO2 is 
known to be biocompatible, with an outstanding chemical permanence and defined 
properties [211]. There are, however, an extensive assortment of SiO2 nano-
formulations that can be applied in biomedical applications, in many different purposes, 
such as: i) common biomedical imaging and integration as imaging contrast agents, ii) 
application in ablative technologies, and iii) application in controlled drug delivery. The 
reason rely on the fact that SiO2-NPs can be produced using multiple synthetic 
techniques that allow to accurately regulate their physical and chemical characteristics 
[212].  
Wise et al., [201] was able to improve auditory nerve survival with nano-engineered 
SiO2-NPs aiming at delivery of neurotrophic factors. The authors investigated the safety 
and efficacy of BDNF-SiO2-NPs as drug delivery system for the cochlea. For that, they 
bilaterally implanted the system into the basal turn of cochleae in deeply deafened 
guinea pigs. The results showed a significantly greater survival of spiral ganglion 
neurons in cochleae that received BDNF-SiO2-NPs as compared to the contralateral 
control cochleae. Also, they were well tolerated within the cochlea, with a tissue 
response that was localized only at the site of implantation in the cochlear base. 
Gonzales Porras et al., [202] described a novel delivery system to motor neurons using 
mesoporous SiO2-NPs encapsulated within a lipid bilayer and modified with the non-
toxic subunit B of the cholera toxin (CTB). This subunit was described to binds to 
gangliosides present on neuronal membranes. The aim was to increase the interaction 
between muscle fibers and motor neurons in case of neuromuscular disorders. It was 
found that the whole system containing SiO2-NPs functionalized with CTB showed 
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greater motor neuron uptake when compared to unmodified lipid bilayers, when tested 
using motoneuron- like NSC-34 cells.   
By its turn, Mehrasa et al., [203] resorted to the electrospinning technique to produce a 
nanocomposite of aligned PLGA and PLGA/gelatin nanofibrous scaffold embedded 
with mesoporous SiO2-NPs. Cultivation of PC12 cells on such scaffolds demonstrated 
that the introduction of mesoporous SiO2-NPs into the matrices leads to improved cell 
attachment and proliferation, as well as longer cellular processes. DAPI staining results 
indicated that cell proliferation on the PLGA 10 wt% mesoporous SiO2-NPs and the 
PLGA/gelatin/10 wt% mesoporous SiO2-NPs scaffolds were outstandingly higher than 
that on the aligned pure PLGA scaffolds, reaching values of 2.5 and 3 folds, 
respectively. 
Liu et al., [204] looked at the problem of anesthetizing PNs for surgeries and other 
procedures. That is because the drug delivery systems that have been used to prolong 
the duration of local anesthetic effect are generally thought of as being essentially 
systems that release local anesthetics in the surrounding area of the nerve. The authors 
have demonstrated that 28 nm hollow SiO2-NPs-containing Tetrodoxin, which is a 
powerful anesthetic, can penetrate into the nerve. This phenomenon contributes to the 
increase in the number of successful nerve blocks as well as the prolongation of nerve 
block. The proved sustained release properties of hollow SiO2-NPs also contributed to 
the extension of nerve block and enhanced safety by slowing release. The discovery of a 
system that can penetrate in PNs could be useful in delivering not only local anesthetics, 
but also a range of other therapeutics. 
3.2.2. Organic NPs  
3.2.2.1. Polymeric NPs 
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Polymers have been considered appealing materials due to their bulk physical 
properties, tunable structural design and architecture as well as customized 
biodegradability [213]. There are countless flexible synthesis methods of polymers and 
the polymer chains allow functionalization with a wide range of molecules. In this 
regard, the final polymer products can be made of different compositions and properties, 
envisioning a wide range of applications and strategies. When in the nano-scale, 
polymer NPs have the amazing capacity of a high drug loading capability [214]. Table 
7 summarizes the relevant reports dealing with the use of organic NPs applied in PNR 
[215-228]. 
Cht is one of the most explored polymers in the field of TE and regenerative medicine. 
To further improve the property of promoting PN regeneration of Cht materials, several 
authors have prepared and explored such polymer in the form of NPs [229-231]. Mili et 
al., [215] prepared the NGF encapsulated Cht NPs (NGF-ChtNPs) by ionotropic 
gelation method with tripolyphosphate as an ionic cross-linking agent and evaluated the 
neuronal differentiation potential of canine bone marrow derived mesenchymal stem 
cells. With a NPs size of 80-90 nm and a NGF loading efficiency of 61%, the NGF-
ChtNPs were found to be cytocompatible to MSC. Furthermore, NGF-ChtNPs can 
release bioactive NGF with the ability to transdifferentiate mesenchymal stem cells into 
neurons.  
Li et al., [216] produced Cht porous hybrid scaffolds with varying amounts of Calcium 
titanate (CaTiO3), which is well known for its high dielectric constant, conductivity 
properties and luminescence. Primary SCs directly cultured onto Cht/CaTiO3 hybrid 
scaffolds with a suitable concentration of CaTiO3 NPs, which was distinguished to be 
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with 5 mg of NPs, could evidently stimulate the attachment, proliferation and biological 
function maintenance of SCs. 
In a very advanced and innovative strategy, Lopes et al., [217] explored the use of a 
microfluidic based DRG neuron culture to test the uptake and transport kinetics of gene 
carrying trimethylated Cht (TMCht)-based NPs actively targeted to neurons. For such, 
the NPs surface was functionalized with the nontoxic and neurotropic C-terminal 54 
kDa fragment of the TeNT heavy chain. The purpose was to develop a way of directly 
deliver any kind of molecules to a relatively inaccessible injection site of PNs and DRG, 
all of this while mimicking a peripheral in vivo route of administration. This 
microfluidic-based 
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Table 7 - The use of organic nanoparticles applied to peripheral nerve regeneration. 
 
Type of nanoparticle Cell type or animal model Main results References 
NGF encapsulated chitosan 
nanoparticles  
Canine bone marrow derived MSCs 
NGF-CNPs are capable of releasing 
bioactive NGF with the ability to 
transdifferentiate mesenchymal stem cells 
into neurons 
Mili et al., 2017 [215] 
Chitosan porous hybrid 
scaffolds with varying amounts 
of Calcium titanate (CaTiO3) 
NP 
SCs  
5mg of NP, could evidently stimulate the 
attachment, proliferation and biological 
function maintenance of Schwann cells  
Li et al., 2017 [216] 
Trimethylated chitosan (TMC)-
based NP 
Microfluidic based DRG neuron 
culture 
This microfluidic-based neuron culture 
showed to be of added value in the 
evaluation of cell–nanoparticle 
interactions, nanoparticle axonal transport 
and safety 
Lopes et al., 2016 [217] 
Thiolated 
trimethyl chitosan (TMCSH)  
grafted with the non-toxic 
carboxylic fragment of 
the tetanus neurotoxin (HC) 
Mice crush injury nerve model  
TMCSH-HC/BDNF NP use stimulated the 
release and expression of BDNF, which 
led to a superior functional recovery after 
injury. Furthermore, there was an 
improvement in crucial pro-regenerative 
actions 
Lopes et al., 2017 [218] 
Hyaluronic acid (HA) doped-
poly(3,4-
ethylenedioxythiophene) 
(PEDOT-HA) NP into a 
chitosan/gelatin (Cs/Gel) matrix 
PC12 cells  
8% PEDOT-HA/Cht/Gel scaffold had a 
higher cell adhesive efficiency and cell 
viability than the other conductive 
scaffolds and could support PC12 cells 
adhesion, survival, and proliferation. Cells 
in conductive scaffold expressed high 
synapse growth gene of GAP43 and SYP 
Wang et al., 2017 [219] 
Polymeric NPs 
 
PEDOT-HA/PLLA film PC12 cells 
Electrical stimulation of 0.5 mA for 
2 hours significantly promoted neurite 
outgrowth with an average value length of 
122 ± 5 μm and enhanced the mRNA 
expression of GAP43 and SYP in PC12 
Wang et al., 2017 [220] 
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Hydroxyapatite nanoparticle-
containing collagen type I 
hydrogel 
SCs; sciatic nerve defect in rats  
significantly enhanced functional behavior 
of the rats compared with the collagen 
hydrogel without NP 
Salehi et al., 2017 [221] 
(NGF)-loaded heparinized 
cationic solid lipid nanoparticles 
(NGF-loaded HCSLNs) 
(NGF-loaded HCSLNs) effect was 
studied in induced pluripotent stem 
cells (iPSCs) 
NGF-loaded HCSLNs can be used for 
differentiation of iPSCs into neurons and 
NGF-loaded HCSLNs with EQ 1 had 
higher viability of iPSCs than NGF-loaded 
HCSLNs with SA 
Kuo et al., 2017 [222] 
(Rop)- polyethylene glycol-co-
polylactic acid (PELA) NP 
Rat postoperative pain model 
Analgesic effect for nerve blocking for 
over 3 days after single administration, 
compared do the 3h of normal 
administration 
Wang et al., 2016 [223] 
3-D biomimetic scaffold, with 
tunable porous structure and 
embedded core-shell NP 
PC12 cells and primary rat cortical 
neurons 
It was found that 3-D scaffolds with NGF 
NP greatly increased the neurite outgrowth 
of PC12 cells and primary cortical neurons  
Lee et al., 2017 [224] 
Dendrimers 
PAMAM and phosphorus 
dendrimers  
Transgenic cells were next injected 
into transected and repaired sciatic 
nerves of isogenic Lewis rats to 
assess GDNF expression 
Cell-based GDNF therapy was shown to 
increase the extent of axonal regeneration, 
while controlled deactivation of GDNF 
effectively prevented trapping of 
regenerating axons in GDNF-enriched 
areas, which was associated with improved 
functional recovery 
Shakhbazau et al., 2013 [225] 
 (PAMAM)–NH2 dendrimers of 
fourth generation - 
pLVTHM/PAMAM 
nanocomplex 
SCs seeded onto GAG matrix 
SCs migration into the GAG-matrix tubes 
separately from proximal and distal ends 
of transected sciatic nerve 
Shakhbazau et al., 2014 [226] 
PAMAM dendrimers of 
generation 5 modified with 
RGD, YIGSR, or IKVAV 
peptides 
Study on the neurite outgrowth of 
PC12 cells after inducing NGF 
differentiation 
The adhesive peptides were successfully 
conjugated to PAMAM dendrimer to 
promote cell-material interaction and 
subsequently cell attachment 
Maturavongsadit, 2016 [227] 
Dendrimers covalently linked to 
near-infra red cyanine-5 
fluorescent dye (D-Cy5) 
Injected the molecules both 
intravitreally and systemically (in 
the rats) or just systemically (in the 
Systemic administration of dendrimers 
allows 
selectively targeting of the ischemic optic 
Guo et al., 2016 [228] 
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monkey) after induction of NAION nerve lesion 
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neuron culture showed to be of added value in the evaluation of cell–nanoparticle 
interactions, namely Cht NPs and PNs. 
One year later, the same authors [218] explored another interesting way to mediate the 
targeted delivery of therapeutic genes to DRG neurons, through the development of 
biocompatible and biodegradable NPs, using the same optimized TMCht-based NPs. 
They proposed the use of such NPs to mediate targeted gene delivery to peripheral 
neurons upon a peripheral and minimally invasive intramuscular administration. To do 
so, they grafted the NPs with the non-toxic carboxylic fragment of the tetanus 
neurotoxin to allow neuron targeting and were explored to deliver a plasmid DNA 
encoding for BDNF in a PN injury model. This complex loaded NPs stimulated the 
release and expression of BDNF, which in turn led to a superior functional recovery 
after injury. Furthermore, there was an improvement in crucial pro-regenerative actions, 
like the increased expression of neurofilament and growth-associated protein GAP-43 in 
the injured nerves as well as significantly higher density of myelinated in the distal 
stump of injured nerves. 
Wang et al., [219] produced a novel porous conductive scaffold that was prepared by 
incorporating conductive HA doped with PEDOT (PEDOT-HA) NPs into a Cht/gelatin 
matrix. As expected, the incorporation of PEDOT-HA into the scaffold increased the 
electrical and mechanical properties while decreasing the porosity and water absorption.  
The results revealed that 8% PEDOT-HA/Cht/Gelatin scaffold had a higher PC12 cell 
adhesive efficiency and cell viability than the other conductive scaffolds. Furthermore, 
cells in the scaffold with 8 wt% PEDOT-HA expressed higher synapse growth gene of 
GAP43 and SYP compared with Cht/Gelatin control group suggesting that 8%PEDOT-
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HA/Cht/Gel scaffold is an attractive cell culture conductive substrate which could 
support neuronal cells survival.  
In a different approach, but using the identical conductive material, PEDOT, the same 
authors [220] produced the same kind of NPs, (HA)-doped PEDOT NPs but instead of 
Cht, prepared PEDOT-HA/PLLA composite films, which were subjected to different 
current intensity to elucidate on the effect of electrical stimulation on neurite outgrowth 
of PC12 cells. Electrical stimulation of 0.5 mA for 2 hours significantly promoted 
neurite outgrowth with an average value length of 122 ± 5 μm. It also enhanced the 
mRNA expression of growth-associated protein (GAP43) and synaptophysin in PC12 
cells as compared with other types of stimulation. These results suggest that PEDOT-
HA/PLLA film combined with electrical stimulation may be an attractive candidate for 
enhancing nerve regeneration. 
Moving to another kind of biomaterials as matrix for embedding NPs, Salehi et al., 
[221] aimed to enhance the efﬁcacy of PNR by combining Ha-NPs with the diameter of 
212 nm in a collagen type I hydrogel, extracted from rats’ tails. In vitro, primary rat SCs 
cultivation on the prepared hydrogel demonstrated a signiﬁcantly higher cell 
proliferation than the tissue culture plate. In vivo, the prepared nanocomposite of 
collagen hydrogel was administrated on the sciatic nerve crush injury in rats showing 
significantly enhanced functional behavior when compared to the collagen hydrogel 
without NPs. 
In a different approach, Kuo et al., [222] were able to produce (NGF)-loaded 
heparinized cationic solid lipid NPs (NGF-loaded HCSLNPs) using heparin-stearic acid 
conjugate, cacao butter, cholesterol, stearylamine (SA) or esterquat 1 (EQ 1) as 
reagents. The immunochemical staining of neuronal nuclei revealed that NGF-loaded 
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HCSLNs can be used for differentiation of induced pluripotent stem cells (iPSCs) into 
neurons and NGF-loaded HCSLNs with EQ 1 had higher viability of iPSCs than NGF-
loaded HCSLNs with SA, proving that EQ 1 may be promising formulation to regulate 
the membrane charge of iPSCs during neuronal differentiation. 
Once again addressing the problem of anesthetizing PNs, Wang et al., [223] designed a 
study to develop and test long-acting NPs and observe the analgesic effects for nerve 
block in a rat postoperative pain model. For such, they developed long-acting anesthetic 
ropivacaine-NPs using polyethylene glycol-co-polylactic acid (PELA). Having in mind 
that the analgesic effect of ropivacaine lasts 3–6 hours after intrathecal injection for 
single use, the ropivacaine-PELA NPs produced an analgesic effect for nerve blocking 
for over 3 days after single administration. 
Lee et al., [224] used a groundbreaking technique to fabricate 3-D biomimetic scaffolds. 
Stereolithography is a laser-based 3-D printing system capable of fabricating aligned 
micro- and macro-size 3-D constructs via a layer by layer assembly method: the 
scaffolds were in the shape of square grid as the base pattern, creating a 3-D porous 
scaffold with internal pores and channels. To complement this technology, BSA–PLGA 
NPs and NGF-PLGA NPs were embedded into the previous matrix. It was found that 3-
D scaffolds with NGF NPs greatly increased the neurite outgrowth of PC-12 cells and 
primary cortical neurons. The authors believe that is not only because of the bioactive 
factor, but also because of the increase of the nano-roughness added by the 
incorporation of NPs. 
These nano-sized molecules have been extensively considered as promising candidates 
for application as drug-delivery carriers in all biomedical fields. They are highly-
branched and symmetrical, branching out from a central core and subdivided into 
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hierarchical branch units, external capping units, with unique structural properties [232]. 
Their important characteristics ascend from their unique and extremely well controlled 
architecture, size and surface properties as compared to traditional linear polymers.  
Such characteristics offer dendrimers the exciting possibility of accommodating other 
molecules in their interior, which characterizes its crucial advantage of acting as non-
covalent drug-encapsulating agents [233]. 
These spherical, biocompatible and biodegradable polymeric-based NPs were reported 
in the late 70s, by Vögtle group, however, they can still be considered as new drug 
solubilizers [234]. 
To our knowledge, little has been done with the dendrimer nanotechnology in PNR and 
repair. On the other hand, there is a vast literature on the use of dendrimers applied in 
the central nervous system [235-239]. 
Shakhbazau et al., [225] reported on proof-of-concept work focused on the application 
of provisional GDNF expression system in injured PNs. For such, they firstly 
engineered primary cultured SCs using dendrimers or lentiviral transduction with the 
vector providing doxycycline-regulated GDNF expression. Transgenic cells were next 
injected into transected and repaired sciatic nerves of isogenic Lewis rats to assess 
GDNF expression. With this study, they were able to demonstrate for the first time the 
genetic modification of SCs with use of dendrimer/plasmid complexes. They have also 
shown for the first time that dendrimer-driven expression of neurotrophic factors is 
compatible with doxycycline-regulated system and ensures tight control of GDNF 
release, as seen in Figure 6B. 
The same authors, [226] hypothesized that a collagen-glycosaminoglycan matrix could 
provide a synthetic way to mimic the SC Basal Lamina (SCBL), since SCBL is a 
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particularly potent substrate for neurite promotion.  Also, the authors wanted to confirm 
the compatibility of such matrix with a virus-free genetic engineering approach, as the 
use of dendrimers. For such, collagen and chondroitin-6-sulfate proteoglycan 
suspension was dispensed into the collagen conduits, which were tested in a sciatic 
nerve defect in rats. Their transfection experiments conﬁrmed 
polyamidoamine (PAMAM) dendrimers ability to transfect SCs and the penetration of 
dendrimer complex into the 3D matrix structure. 
The 5th generation PAMAM dendrimers were used by Maturavongsadit et al., [227] 
with the goal of enhancing cellular responses, namely the promotion of increased 
cellular adhesion. The real aim of the work consisted in both assess the possibility of 
functionalizing the dendrimers with several cell-binding motifs, such as RGD, YIGSR, 
or IKVAV peptides and determine how it affects cellular responses. The RGD, YIGSR, 
or IKVAV functionalized PAMAM coated substrate could promote evident neurite 
outgrowth of PC12 cells on all of the peptides-modified PAMAM coated substrates by 
day 1. Quantitative image analysis of the neurite lengths on all of the peptide-modified 
PAMAM surfaces were in range of 18–20, 50–60, and 90–115 μm on day 1, 2 and 4, 
respectively, which were significantly higher than the neurite length on the control 
surfaces. 
In an attempt to address non-arteritic anterior ischemicoptic neuropathy and knowing 
that dendrimers should be directed and collected in inflammatory cells upon systemic 
administration, Guo et al. [228] tested the difference between locally and systemic 
injection of traceable dendrimers covalently linked to near-infra red cyanine-5 
fluorescent dye. The results revealed that systemic dendrimer administration provided 
the best penetration in the optic neuropathy lesion site when injected shortly after 
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induction, leading to the conclusion that systemic administration of dendrimers allows 
selectively targeting of the ischemic optic nerve lesion. 
3.2.3. Biologically derived NPs 
Intercellular transfer of macromolecules through vesicles, known as exosomes, has 
become the subject of increasing interest as a novel means for intercellular crosstalk. 
Exosomes can be considered one kind of NPs. However, unlike the ones mentioned in 
the sections before, these are biologically derived.  
By definition, exosomes are small membranous vesicles or nanovesicles with 40 to 100 
nm in size, with a density of approximately 1.13–1.19 g/cm2 [240].  
Regarding their development, exosomes are produced via the internal budding of 
endosomes to form multi-vesicular bodies that fuse with the plasma membranes to 
release exosomes into the surrounding environment. Based on the cell types they are 
originated from, they contain a wide range of factors, such as proteins, lipids, RNA, 
mRNA and miRNA [241]. These elements that are carried by exosomes can be termed 
as “cargo” and will be delivered either to the surroundings cells or taken to have action 
in more distant cells. With this, it is understandable that depending on the cargo content, 
different phenomena can happen to the recipient cells, including its DNA reprograming 
[242]. Not only the cargo will have an impact on the receptor cell, but also the surface 
membrane of the exosomes contains proteins that act as makers [243]. Exosomes are 
therefore recognized as new form of intercellular communication between cellular 
components, but without the expected cell-to-cell direct contact. After understanding the 
way exosomes work, the potential of such NPs can be assumed for drug delivery and 
other therapies [244]. 
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It is known today that exosomes are deeply involved in neuronal activity, from its 
protection, degeneration, development and even regeneration. Many studies have shown 
that CNS components are capable of releasing exosomes [245-247]. For instance, 
studies indicate the release of exosomes by neurons [248], microglia [249], astrocytes 
[250], oligodendrocytes [251], and neural stem cells [252]. However, its role in the PNS 
has only been showed much more recently. Figure 7 embodies some exciting results 
obtained from research works focused on exosomes. 
Figure 7 
In 2008, Court et al., [253] proved that in damaged PNs, SCs deliver vesicles containing 
ribosomes into the axon and its contents are then released. Therefore, exosomes can 
deliver mRNA and ribosomes to injured nerves and promote local protein synthesis 
which is needed for the process of Wallerian degeneration and consequent regeneration. 
In this context, the same author [254] has shown that labelled ribosomes in the nerve are 
derived from the SCs. However, not all exosomes secreted by SCs have positive effects. 
In fact, SCs have been shown to secrete exosomes containing pathogenic prions in vitro, 
therefore existing the possibility that these pathogens might be released from the PNS to 
infect the CNS [255]. Recent literature on the relation between exosomes and PNR is 
reviewed and summarized in Table 8 [256-260]. 
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Table 8 - Exosomes in scope of peripheral nerve regeneration. 
Type of nanoparticle Cell type or animal model Main results  References  
SCs exosomes 
SCs, fibroblasts, DRGS, Rat crush 
injury model 
Dedifferentiated SCs secrete nano-vesicles known as exosomes 
which are specifically internalized by axons. They increase 
axonal regeneration both in vivo and in vitro 
Lopez-Verrilli et al., 2013 [256] 
MSCs’s derived exosomes  
Menstrual MSCs Bone Marrow 
MSCs, umbilical cord MSCs and 
chorion MSCs 
MenSC exosomes showed superior effects on the growth of the 
longest neurite in cortical neurons  
Lopez-Verrilli et al., 2016 [257] 
Exosomes derived from blood 
serum in mice 
Mice and partial sciatic nerve 
ligation model in rat 
demonstrated that miR-21, miR431, and miR-511-3p in the 
DRG gradually increased in an IL-6-dependent manner during 
the development of neuropathic pain 
 
Hori et al., 2016 [258] 
DRGs exosomes DRGs, nerve injury in mice 
Up-regulation and release of miR-21 contributed to sensory 
neuron–macrophage communication after damage to the 
peripheral nerve 
 
Simeoli et al., 2017 [259] 
NG2+ cells exosomes NG2+ cells, rat neurons 
The release of Retinoic Acid in association with exosomes 
provided a permissive substrate to neurite outgrowth 
Gonçalves et al., 2018 [260]  
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In 2013, Lopez-Verrili et al., [256] focused on the regulation of axons by SCs mediated 
secreted vesicles and studied this means of communication between these two role 
players of PNS, to support neuronal and axonal regeneration after an injury. The authors 
explored the hypothesis that exosomes released from SCs would be uptaken by axons in 
a way to regulate intrinsic mechanisms of neuronal regeneration. They have in fact 
demonstrated, both in vivo and in vitro that SCs secrete exosomes and that they are 
selectively internalized by axons. To support their exciting findings, they further proved 
that SC-secreted exosomes, but not fibroblast-derived ones, markedly increase axonal 
regeneration. Images regarding this work can be seen in Figure 7.  
The same authors compared the effect of human menstrual MSCs (MenSCs) mediated 
by three different ways: cell–cell contact, by their total secretome or by secretome-
derived extracellular vesicles on neuritic outgrowth in primary neuronal cultures [257]. 
As exciting conclusion, they found that the contact of MenSCs with cortical neurons 
inhibited neurite outgrowth as their total secretome containing exosomes enhanced it. 
To complete their hypothesis of using exsomes derived from Stem cells, they found that 
extracellular vesicle fractions showed a distinctive effect. While the exosome-enriched 
fraction enhanced neurite outgrowth, the microvesicle-enriched fraction displayed an 
inhibitory effect, suggesting that exosomes derived from MenSCs could have possible 
applications in PNR. 
To address the problem of neuropathic pain and knowing that it is highly likely that 
miRNA plays some key roles in the formation of pain, Hori et al., [258] performed a 
miRNA array analysis in the DRG of mice with sciatic nerve ligation and investigated 
the possible changes in DRG-associated miRNAs in exosomes derived from blood 
serum in mice. They demonstrated that miR-21, miR-431, and miR-511-3p in the DRG 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
79 
 
gradually increased in an IL-6-dependent manner during the development of 
neuropathic pain, but only miR-21 in exosomes extracted from blood was secreted in 
mice with sciatic nerve ligation. With these results, the authors believe that amplified 
blood exosomal miR-21 after sciatic nerve ligation may be seen as a diagnostic 
biomarker for neuropathic pain. 
Still considering the subject of neuropathic pain, Simeoli et al., [259] show that 
DRG neuron cell bodies release extracellular vesicles, including exosomes containing 
miRs. They have demonstrated that pure sensory neuron-derived exosomes released by 
capsaicin are readily phagocytosed by macrophages in which an increase in miR-21-5p 
expression promotes a pro-inflammatory phenotype. This suggests that upregulation and 
release of miR-21 contribute to sensory neuron-macrophage communication after 
damage to the peripheral nerve. 
Gonçalves et al., [260] identified a novel mechanism by which neuronal retinoic acid 
receptor β (RARβ) activation results in the endogenous synthesis of retinoic acid, which 
is released in association with exosomes and acts as a positive cue to promote 
axonal/neurite outgrowth. The excitement of this discovery relies in the fact that their 
data suggests the possibility of an advantageous therapeutic approach where a RARβ 
agonist could be used for a much shorter period than the one required for the full 
regeneration of the axon. 
These biologically derived NPs are a promising field in the PNR area. One can envision 
the use of SCs autologous patient-specific exosomes to enhance nerve regeneration. 
However, the downside of this is the same as the use of autografts, as one healthy nerve 
needs to be sacrificed for such [261]. However, stem-cells play a major role here, since 
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it is well know that Schwann-like cells can be obtained from both MSCS and Adipose 
Derived Stem Cells (ACSs) and so could their exosomes.  
Nevertheless, the above-mentioned studies might result in significant improvements for 
the patients in the future when the use of exosomes is used in the clinical setting, 
however that vision is still a step ahead.  
3.2.4. NPs Toxicity  
Although related to various successful and innovative discoveries, the use of NPs is not 
completely safe and various reports have been considering this subject [262-265]. This 
is mainly due to the fact that such particles in the nano-size interact directly with cells 
and lead to the formation of reactive oxygen species, leading to oxidative stress [262]. 
In fact, and although the advantages of nanotechnology are undeniable, people are now 
generally unprotected against various nano-scale materials. This fact makes them 
extremely powerful, as they may assist in the clinical practice, but might also become a 
threat to human life [266]. Because of their size, it is expected that NPs with less than 
10 nm behave similar to a gas and can easily enter human tissues [267].  
Further cytotoxicity can be found in positively charged NPs, as they have the capacity 
to interact and induce disruptions in the living cells plasma membranes [268]. 
More specifically, aluminum-based NPs, which contribute to 20% of all nano-sized 
chemicals, were demonstrated to have cytotoxicity, as they disrupt cellular viability, 
alter mitochondrial function, increase oxidative stress, and modify tight junction protein 
expression of the blood brain barrier. Also, genotoxicity has been studied for these 
molecules, revealing dose-dependent genotoxic properties [269, 270].  
Silver NPs are considered one of the most cytotoxic NPs. When compared to others, 
these NPs have shown more toxicity in term of cell viability, generation of reactive 
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oxygen species and lactate dehydrogenase (LDH) outflow. As they accumulate in 
different parts of the body, they have been identified in various organs, including lungs, 
spleen, kidney, liver, and brain [271]. 
Zinc oxide NPs have also been studied regarding their cytotoxicity on bacteria and 
mammalian cells. Their most common toxic effects are related to cell membrane 
damage and increased oxidative stress, which have been reported in various mammalian 
cell lines [272]. 
Often, the toxicity is provided not by the NPs themselves, but by the coatings many 
time used to facilitate the processes in biomedical applications, which is the case of 
polydimethylamine, found to have cytotoxic effects in cortical neurons isolated from 
chick embryos [273].  
In the end, one must have precaution when using these nano-scale materials, since they 
can in fact interact with organisms in a cellular lever, especially in the nervous system. 
However, their benefits for the future of the science and medical community concerning 
PN treatment and repair are undeniable and many examples of that were described 
above.   
3.3.  Nanofibers  
Nanofibers are fibers with diameters one or two orders of magnitude smaller than 
conventional fibers that closely mimic the ECM. These fibers have a uniquely large 
surface area-to-mass ratio and can be usually produced by electrospinning [274] and 
self-assembly [275] techniques. 
Electrospinning is a simple and versatile electrodynamic practice in which a polymer 
solution can be spun by engaging a high potential electric field to obtain nano-scale 
long fibers, meaning it relies on the electrostatic repulsion between surface charges to 
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continuously draw nanofibers from a viscoelastic fluid. It includes the quick 
evaporation of solvent and solidification of droplets to form fibers [276].  
As the external electrical field is applied, the liquid in the metallic needle is induced to 
elongate at the tip of the needle and takes on the form of a cone which is extended in the 
form of a jet. A typical electrospinning apparatus contains four main components: i) a 
high voltage source (1–30 kV), ii) a metallic needle or capillary, iii) a syringe pump, 
and iv) a grounded conductive collector, that among many shapes, usually is a simple 
flat plate or rotating mandrel [277]. 
An incredible amount of materials can be used for electrospinning, including polymers, 
ceramics, small molecules, and their combinations [278]. Not only different 
biomaterials can be used, but the final smooth nanofiber meshes can be adapted to 
create nanofibers with a number of secondary structures, comprising porous, hollow, or 
core−sheath structures. Furthermore, nanofibers can be collected into ordered arrays or 
hierarchical structures by manipulation of their alignment, stacking, and/or folding. 
Therefore, it has been recognized at least for a decade now that nanofibrous scaffolds 
also offer great potential in the field of neural tissue engineering, as they are able to 
mimic native tissue tubular structures including axons, microtubules and ion channels 
[279, 280].  
Because of the potential related to the use of nanofibrous in PN tissue engineering, 
many interesting publications have emerged in the last few years. Extraordinary results 
obtained with reviewed random, aligned and conductive nanofibers can be seen in 
Figure 8, as well as the electrospinning apparatus (Figure 8A). Table 9 summarizes the 
reports on use of the different nanofibers applied in PN regeneration that will be further 
discussed [86, 87, 281-297]. 
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Figure 8 
3.3.1. Random nanofibers 
As mentioned before, nanofibrous mats are very successful due to its resemblance to 
ECM. However, in a study conducted by Gnavi et al., [281] the influence of the fiber 
size on explanted cultures of SCs and DRGs was studied after producing micro- or 
nanofibers made of gelatin by electrospinning. In one hand, nanofibers promoted cell 
spreading and actin cytoskeleton organization, increasing cellular adhesion and the 
proliferation rate. On the other hand, both migration rate and motility, quantified by 
means of carrying out trans-well and time-lapse assays respectively, were greater in 
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cells cultured on micro-fibers. That study clearly indicates that topography of 
electrospun gelatin fibers can be adjusted to modulate SC and axon organization 
(Figure 8B). 
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Table 9 - The use of nanofibers applied to peripheral nerve regeneration. 
 Type of nanofiber Cell type or animal model Main results References  
Random 
nanofibers 
Gelatin micro- or nanofibers SCs and DRGs 
The topography of electrospun gelatin fibres can be 
adjusted to modulate SC and axon organization, since 
it affects parameters such as motility or cytoskeleton 
organization 
Gnavi et al., 2015 [281] 
PCL and MeCbl Nanofibers  
Cortical neurons; rat sciatic 
nerve crush injury model 
Local administration of MeCbl at PN injury sites 
promoted nerve regeneration and enhanced functional 
recovery in a rat sciatic nerve crush injury model 
Suziki et al., 2017 [282] 
poly (e-
caprolactone)/collagen/nanobio
glass (PCL/collagen/NBG) 
nanofibrous conduits 
transplanted with hEnSCs 
Human endometrial stem cells 
(hEnSCs) 
PCL/collagen/NBG nanofibrous conduit filled with 
hEnSCs is a suitable strategy to improve nerve 
regeneration after a nerve transaction in rat 
Mohamadi 2017 [283] 
electrospun PCL porous conduit 
with O-CCH as a longitudinally 
oriented microstructure filler 
DRG, Schwann cells; rat sciatic 
nerve defect 
Functional results indicated that the CCH/PCL 
compound scaffold induced comparable functional 
recovery to that of the autograft group at the end of 
the study 
Huang et al., 2017 [284] 
Emulsion electrospun poly (L-
lactic acid) (PLLA) nanofibrous 
Induced pluripotent stem cells-
derived neural crest stem cells 
(iPSCs-NCSCs) 
 
VEGF and NGF in emulsion electrospun nanofibrous 
scaffold had a synergistic effect on regeneration of 
vascularized nerve tissue 
Xia et al., 2018 [285] 
PLCL/SF nanofiber sponges 
 
SCs; rat sciatic nerve model 
The results demonstrated that nanofibers -sponge 
containing conduit performed better than the hollow 
conduit 
Sun et al., 2017 [286] 
PCL and collagen/PCL blends 
incorporated in a gelatin matrix 
and inserted in collagen tubes 
Rat sciatic nerves defect 
 
When implanted in 15 mm sciatic nerve defect, 
animals containing collagen/PCL fibers had higher 
extent of recovery when compared to animals that 
had received empty implants, but not as good as with 
autologous nerve transplantation 
Kriebel et al., 2017 [287] 
Aligned 
nanofibers 
Randomly oriented and aligned 
poly(methyl methacrylate) 
DRGs and SCs 
When co-cultured, DRGs and SCs revealed that on 
aligned nanofibers, neurites and SCs had a higher 
 
Xia et al., 2014 [288] 
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nanofibers chance of co-localization than on randomly oriented 
nanofibers 
Randomly oriented and aligned 
poly(methyl methacrylate) 
nanofibers 
DRGs and SCs 
When co-cultured, DRGs and SCs revealed that on 
aligned nanofibers, neurites and SCs had a higher 
chance of co-localization than on randomly oriented 
nanofibers 
Xia et al., 2016 [86] 
Aligned PHBV nanofiber rat sciatic nerve defect 
Nanofibers in an aligned orientation favored stem cell 
growth and elongation and indicated that the FGF2-
miR-218 induction approach combined with the 
(PHBV)-3D nanofiber scaffolds facilitated the nerve 
regeneration 
Hu et al., 2017 [87] 
Randomly oriented and aligned 
poly(L-lactic acid) nanofibrous 
scaffolds 
iPSC-derived neural stem cells  
Compared with randomly, the aligned PLLA 
nanofibers greatly directed neurite outgrowth from 
the iNSCs and significantly promoted neurite growth 
along the nanofibrous alignment 
Lin et al., 2018 [289] 
Aligned electrospun polylactic 
acid (PLLA) microtube array 
membrane (MTAM) 
Co-cultures of rat fetal neural 
stem cells (NSC) and astrocytes  
MTAM is a better co-culture platform than the 
traditional Transwell system 
Tseng et al., 2017 [290] 
Aligned electrospun 
Methacrylated hyaluronic acid 
nanofibers 
DRGs 
DRGs seeded o the scaffolds revealed that the 
combination of NGF released from the microspheres 
and the aligned nanofibers significantly enhanced 
neurite outgrowth 
Whitehead et al., 2017 
[291] 
PCL electrospun nanofibers 
were mixed with gelatin and 
further embedded in 3D printed 
hydrogel scaffold 
Primary cortical neurons 
 
It was possible to fabricate 3D neural tissue 
constructs by combining 3D bioprinting and 
electrospinning techniques and the neurons aligned in 
the aligned nanofibers 
Lee et al., 2016 [292] 
3D hierarchically aligned fibrin 
nanofiber hydrogel (AFG) 
SCs, DRGs; 
 Rat sciatic nerve injury 
The developed scaffold supports SCs cable formation 
and axonal regrowth within 2 weeks, with similar 
results to the autograft after short and long-term 
studies 
Du et al., 2017 [293] 
 
Nanofibers 
combined 
with 
conductive 
materials 
Polyaniline and silk fibroin 
(PASF) nanofibers 
SCs; 
sciatic nerve nerve defect 
12 months after implantation it was verified enhanced 
neuro-regeneration 
Das et al., 2017 [294] 
PPy(lactide acid) conductive 
fiber-film (CFF) coated with 
cell-derived extracellular matrix 
PC12 cells 
The combination of ECM-CFF with electrical 
stimulation could improve the nerve regeneration by 
encouraging neural-cell adhesion, neurite growth and 
Zhou et al., 2017 [295] 
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derived from L929 cells (CFF-
ECM) 
extension 
PLA/PPy nanofibrous scaffold 
human umbilical cord MCSs, 
SCs 
PLA/PPy nanofibrous scaffold containing 15% PPy 
with sustained conductivity and aligned topography. 
Additionally, the direction of cell elongation on the 
scaffold was parallel to the direction of fibers  
Zhou et al., 2016 [296] 
Conductive PPY/PLCL conduits 
were synthesized by 
polymerizing pyrrole coated on 
Poly (l-lactic acid-co-ε-
caprolactone) 
 PC12 cells, DRG;  
Rat sciatic nerve defect 
The PPY/PLCL conduits with electrical stimulation 
showed a similar performance compared with the 
autograft group, and significantly better than the non-
stimulated PPY/PLCL conduit group showing great 
potential for PN regeneration 
Song et al., 2016 [297] 
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In a noteworthy publication, Suzuki et al., [282] hypothesized whether an electrospun 
nanofiber sheet incorporating methylcobalamin (MeCbl), one of the active forms 
of vitamin B12 homologues, when delivered locally to the PN injury site, would 
contribute to promoting nerve regeneration. In vitro, cortical neurons were cultured in 
microfluidic chambers and it was seen that local administration of MeCbl to 
the axon compartment promoted axonal outgrowth equal to axon and administration of 
MeCbl. In vivo, when wrapping the nanofiber sheet around the PN injury, local 
administration of MeCbl promoted nerve regeneration and enhanced functional 
recovery. 
In another study comprising random nanofibers, Mohamadi and colleagues [283] aimed 
at evaluating the sciatic nerve regeneration potential in the rat nerve transaction injury 
model followed by implantation of poly(e-caprolactone)/collagen/nanobioglass 
(PCL/collagen/NBG) nanofibrous conduits containing human endometrial stem cells 
(hEnSCs). To do so, the authors first prepared the respective conduit by electrospinning. 
Afterwards, a fibrin gel containing hEnScs with a concentration of 1x105 cells/mL was 
injected in the conduits and implanted. After extensive evaluation, the authors 
demonstrated that hEnSCs grafted inside a PCL/Collagen/NBG conduits have the 
potential to improve sciatic nerve regeneration, however without knowing the exact 
roles of hEnSCs in the process.  
Huang et al., [284] combined the stage-wise approach of electrospinning to produce the 
outer conduit made of random nanofibers with the directionally freezing orientated 
collagen-chitosan (O-CCH) filler, since incorrect positioning or distribution of 
intraluminal fillers and consequent incorrect wiring of the regenerating axons might 
result in regeneration failure. After proper characterization, collagen/chitosan in the 
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reason (1:1) was selected for filler fabrication and a wall thickness of 400 μm was 
selected for PCL sheath production. 3D-reconstruction further revealed that the O-CCH 
filler unveiled a longitudinally oriented microstructure with 85% of pores and the 
electrospun PCL porous sheath with pore sizes of 6.5 ± 3.3 μm that prevented fibroblast 
invasion. Overall, in vitro and in vivo studies up to 12 weeks indicated that the O-
CCH/PCL scaffolds could promote axonal regeneration and migration. 
Xia et al., [285] was able to incorporate VEGF and NGF on the surface and in the core 
of emulsion random electrospun PLLA nanofibrous scaffold, respectively, which was 
capable of dual delivery. In this sense, VEGF and NGF had a sequential release pattern, 
in which most of the VEFG was released in the first few days as it was embedded in the 
surface of the meshes, but the NGF could be continuously released for more 
than 1 month, as it was captivated in the interior of the nanofibers. In vitro, the use of 
such scaffold could enhance the neural differentiation of iPSCs-derived neural crest 
stem cells (iPSCs-NCSCs). Additionally, this scaffold was applied to a critical sized 
defect in rat sciatic nerve model in vivo, which revealed a significant improvement of 
neovascularization as well as nerve healing after 3 months post-operation.  
Sun et al., [286] reversed the previous strategy of using the nanofibers meshes as 
conduits and used it instead as a filler. Poly (L-lactic acid-co-ε-caprolactone)/SF 
(PLCL/SF) nanofiber sponges were used as fillers to prepare 3D nanofibers sponges 
containing conduit. The filler fabricated by electrospinning and subsequent freeze-
drying demonstrated abundant macropores, high porosity and superior compressive 
modulus. In vitro cell viability studies indicated that the fabricated conduit could 
enhance the proliferation of SCs due to the macro-porous structure, since hematoxylin-
eosin and immunofluorescence staining confirmed that these cells infiltrated into the 
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nanofiber-sponges. Afterwards, the conduit was implanted in the rat sciatic nerve defect 
model to evaluate the effect in vivo, which in general performed better than the hollow 
conduit group.   
Using the same strategy of applying nanofibers as a luminal filler, Kriebel et al., [287] 
developed a cell-free, 3D scaffold for axonal guidance for long-distance nerve repair in 
which the nanofibers of made of biodegradable PCL and collagen/PCL blends were 
incorporated in a gelatin matrix and inserted in collagen tubes, in a complex strategy 
developed earlier by the same author.   
When implanted in 15 mm sciatic nerve defect, animals containing collagen/PCL fibers 
had higher extent of recovery (compound muscle action potentials, motor functions of 
the hind limbs) when compared to animals that had received empty implants, but not as 
good as with autologous nerve transplantation. 
3.3.2. Aligned nanofibers 
Many works have been focusing on horizontally aligned nanofibers, since in 2006 [298] 
and 2008 [299] it was proved the high potential of anisotropic topographies for PNR. 
This is because of the natural formation of the Bands of Bungner after an injury, which 
are oriented columns of laminin-1 and aligned SC. Regenerating fibers then enter the 
gap and follow these Bands of Bungner, reaching the distal end of the severed nerve, re-
enervating the distal target, guided by the horizontal aligned cues. 
Xia et al., [288] aimed at meticulously analyze the specifics of neurite growth of DRGs 
on randomly oriented and aligned poly(methyl methacrylate) (PMMA) nanofibers and 
understand the relationship between neurites and nanofibers, as well as the alignment or 
random orientation of the nanofibers. The authors verified a relationship between 
neurites and nanofibers, as the neurites of DRGs were in close contact with the substrate 
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nanofibers, and the neurites seemed to follow aligned nanofibers more than randomly 
oriented nanofibers. Most importantly, when co-cultured, DRGs and SCs revealed that 
on aligned nanofibers, neurites and SCs had a higher chance of co-localization than on 
randomly oriented nanofibers, which is of key importance in the process of nerve 
regeneration.  
The same authors [86] described aligned electrospun PMMA nanofibers as a SC-
loading scaffold in vitro, by monitoring the GFP-containing SCs cultured on nanofibers. 
They found that aligned nanofibers provided better support for the cells than did non-
aligned nanofibers, as relationships between SCs and fibers could clearly be seen. Once 
again, the co-culture experiment showed on aligned nanofibers both SCs and DRGs 
adhered and elongated along the axes of the fibers, so they had a higher chance of co-
localization is definitely beneficial to the ensure the process of myelination. 
Hu et al., [87] were able to combine biomaterials and stem cells in an approach where 
neuronal differentiation of stem cells was based on the temporally sequential use 
of miR-218 and Fibroblast Growth Factor 2 (FGF2) in vitro, (FGF2-miR-218 induction 
approach). Furthermore, the authors applied this novel approach in repairing sciatic 
nerve damage in vivo.  
The neuronally differentiated ASCs were integrated with the 3D aligned nanofibers and 
implanted in a 10 mm transected rat sciatic nerve defect in vivo. The results showed 
that, compared to randomly aligned nanofibers, the nanofibers in an aligned orientation 
favored stem cell growth and elongation. Furthermore, FGF2-miR-218 induction 
approach combined with the poly(hydroxybutyrate-co-3-hydroxyvalerate)(PHBV) 3D 
nanofiber scaffolds facilitated nerve regeneration. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
92 
 
In a complex report also involving biomaterials and stem cells, Lin et al., [289] used 
mouse iPSCs generated from mouse embryonic fibroblasts with the non-integrating 
episomal vectors pCEP4-EO2S-ET2K and pCEP4-miR-302-367 cluster and 
differentiated them into NSCs as transplanting cells. Electrospinning was then used to 
fabricate randomly oriented and aligned PLLA nanofibers.  Compared with randomly 
oriented, the aligned PLLA nanofibers greatly directed neurite outgrowth from the 
iNSCs and significantly promoted neurite growth along the nanofibrous alignment. 
Tseng et al., [290] developed an innovative system where a substrate made of aligned 
electrospun PLLA microtube array membrane (MTAM) was successfully developed as 
a cell co-culture platform. Its architecture is based on one-to-one connected, ultrathin, 
nano-scale fibers that are set in an arrayed creation. To study the co-culture potential, rat 
fetal NSC and astrocytes were examined by relating the outcome of a typical transwell-
based co-culture system and that of MTAM-based co-culture system. Greater cell 
viability of NSC was detected when cultured in electrospun PLLA MTAM and RT-PCR 
exposed a robust interaction between astrocytes and NSC confirming that MTAM is 
clearly a better co-culture platform than the traditional Trans-well system. 
Making use of aligned nanofibers, Whitehead et al., [291] developed a conduit with all 
mechanical, chemical, and topographical cues destined for PNR. Methacrylated-HA was 
electrospun into aligned fibers, with poly-lactic-co-glycolic acid microspheres to deliver 
NGF. DRG seeded in the scaffolds revealed that the combination of NGF release from 
the microspheres and the aligned nanofibers significantly increased neurite growth 
(Figure 8C). 
To address some limitations of the regular 3D printing, Lee et al., [292] combined 
stereolithography and electrospinning techniques to fabricate a novel 3D biomimetic 
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neural scaffold with a tunable porous structure and highly aligned nanofibers. PCL 
nanofibers were mixed with gelatin and further embedded in 3D printed hydrogel 
scaffold. Then printable hydrogel inks, composed of 40 wt% Polyethyleneglycol (PEG), 
60 wt% diacrylate (PEG-DA) and photo-initiator (0.5 wt% of PEG-DA concentration) 
covered the electrospun fiber. As expected, the results indicated that 3D printed 
scaffolds with electrospun fibers significantly improved NSC adhesion when compared 
to those without the fibers. Notably, the scaffold with PCL/gelatin fibers greatly 
increased the average neurite length and directed neurite extension of primary cortical 
neurons along the nanofibers. 
Du et al., [293] was capable of producing a 3D hierarchically aligned fibrin nanofiber 
hydrogel through electrospinning and molecular self-assembly to resemble the 
architecture and biological function of the native fibrin cable mentioned before as bands 
of Bungner. In this produced biomaterial, nanofibers are laid in the surface of the 
hydrogel. Firstly, in vitro assays with SCs and DRGs showed fast and directional cell 
adhesion and migration, as well as alignment of neurites. Secondly, the aligned 
hydrogel was then used as a potential intraluminal substrate in a bioengineered chitosan 
tube to bridge a 10-mm long sciatic nerve gap in rats, revealing a beneficial 
microenvironment to support SCs cable formation and axonal regrowth within 2 weeks, 
with similar results to the autograft after short and long-term studies. 
3.3.3. Nanofibers combined with conductive materials 
Das et al., [294] synthetized and described for the first time PA-based nerve conduits, 
expressing the safety and efficacy of the conduits in PN injuries. For the production of 
such conduits, the nanocomposite was synthesized by electrospun a mixture of PA and 
SF, in which the silk nanofibers were uniformly coated with PA. Subsequently, by 
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means of rolling of the electrospun sheet over a stainless-steel mandrel, tubular shaped 
nerve conduits are molded. It was verified that implanted PA-SF conduits seeded with 
SCs exhibited exceptional nerve conduction velocity, compound muscle action 
potential, motor unit potential, visible growth of healthy tissue along the nerve gap and 
thick myelination of axons 12 months after implantation, indicating enhanced neuro-
regeneration, when compared to similar electrically conductive conduits.  
Using PPy as the conductive material to blend in the nanofibers, Zhou and colleagues 
[295] could enhance neurite adhesion, alignment and elongation of PC12 cells on PPy-
PLA conductive fiber-film (CFF) coated with cell-derived ECM derived from L929 
cells (CFF-ECM). By combing the developed material with electrical stimulation, it was 
verified that PC12 cell adhesion rate, neurite-bearing cell rate, neurite alignment rate 
and neurite length on ECM-CFF were significantly larger than the corresponding values 
on bare CFF.  
Using the same materials, PPy and PLA, Zhou et al., [296] embedded PPy into PLA 
nanofibers via electrospinning and fabricated a PLA/PPy nanofibrous scaffold. In vitro 
assays with human umbilical cord mesenchymal stem cells as well as SCs proved the 
scaffolds had good biocompatibility with such cells. Additionally, the direction of cell 
elongation on the meshes containing 15% PPy proved sustained conductivity and 
aligned topography. 
Song et al., [297] investigated the abilities of direct current electrical stimulation 
through electrospinning conductive polymer composites composed of PPy and PLCL 
(PPY/PLCL) in PN regeneration. PC12 cells and DRGs cells cultured on PPY/PLCL 
scaffolds were stimulated with 100 mV/cm for 4 hours per day. After that, the median 
neurite length and cell viability were measured in PC-12 cells and the levels of BDNF, 
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GDNF and NT-3 were analyzed in DRG neurons, revealing that not only the quantity of 
PC12 cells increased, but also the median neurite length increase significantly after 
electrical stimulation. Regarding the neurotrophic factors, all of them were up-
regulated, which was detected by western blot, RT-PCR and Elisa quantifications.  
When implanted in vivo and after electrical stimulation, the results revealed satisfying 
functional recovery and equivalent morphological recovery to nerve autografts (Figure 
8D). 
After this review of the lately published works comprising both random and aligned 
nanofibers, as well as mixed with conductive polymers, one can easily see the huge 
potential of these nanotechnologies. This is primarily related with three points: i) its 
resemblance with ECM, to which PNS cellular components easily adhere, ii) the 
advantage of this technology that allows to change its architecture to extremely aligned 
nanofibers, which is of crucial significance in PNR, as the process of nerve regeneration 
itself lies in the formation of aligned fibrin cables and ultimately possibly to augment 
nerve regeneration, and iii) the electrospinning allows the easy incorporation of many 
kinds of substrates and molecules, such as vitamins, conductive polymers or other 
polymers that might act as co-adjuvants or stimulants in the process of regeneration.   
3.4. Topographic cues at micro- and nano-scale  
There is now sufficient body of evidence which states that artificial physical cues, such 
as topography, can have an important impact on the neuronal cell functions [300]. In 
fact, a relatively new theory states that the growth cone guidance follows the 
‘‘substrate-cytoskeletal coupling’’ model [301]. Accordingly, “growth cones can move 
forward if they are capable of coupling intracellular motility signals to a fixed 
extracellular translocation substrate via cell surface adhesion receptors”.  
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The power of topography and its influence on neuronal cells has been established as 
early as 1914, when R. G. Harrison first cultured embryonic frog in the threads of a 
spider web. Surprisingly, he observed that the cells specially stretched along the support 
given by the threads [302].   
With the new production techniques of micro- and nano-topographies, new types of cell 
culture platforms can be established, and the influence of a panoply of topographical 
cues can be studied in what regards cellular functions, such as cytoskeleton 
morphology, proliferation or differentiation. 
However, most of the structures that were studied and had the power to affect axonal 
growth and alignment were of micro-sizes [303-305]. 
In the field of topography, there are several methods available for the development of 
patterned biomaterial surfaces, ranging from simple manual scraping to highly 
controlled manufacture methods. Contact printing, [306] lithography, [307] microfluidic 
patterning [308] and electrospinning [284] are some of the techniques that allow a more 
precise and nano-scale physical cues to be achieved. Table 10 resumes the use of nano-
scaled topographic cues applied in PN regeneration [309-313]. Figure 9 depicts some of 
the most interesting achievements related to topographic and neuronal investigations. 
In what concerns nanotopography, Ferrari et al. [309] studied the neuronal polarity of 
PC12 cells on cyclic-olefin-copolymer grooves of 350 nm depth and 500 nm groove 
width with varying ridge width. It was shown that cells would fluctuate from monopolar 
and bipolar to multipolar morphology, as the ridges width shifted, as seen in Figure 9A.  
The same authors [310] described an experience where PC12 cells were in contact with 
nano-gratings, which are periodic sub-wavelength structures, where there is an 
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alternating of submicron lines of ridges and grooves, with 350 nm depth and with line 
widths and pitches of 500 nm were fabricated by nanoimprint lithography. 
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Table 10 - Nano-scale topographic cues applied to peripheral nerve regeneration. 
Type of nanomaterial Cell type or animal model Main results References  
Nanogratings with 350 nm depth and with line widths 
and pitches of 500 nm were fabricated 
PC12 cells 
Nanogratings with the smallest ridge size (500 nm) strongly 
favor bipolar cells and a transition to multipolarity is obtained 
increasing the ridge width to 1500 nm 
Ferrari et al., 2011 
[309] 
Nanogratings with 350 nm depth and with line widths 
and pitches of 500 nm were fabricated 
 
PC12 cells 
Topographical guidance in PC12 cells is modulated by the 
activation of alternative neuronal differentiation pathways  
Ferrari et al., 2010 
[310] 
X-ray lithography was used to pattern silicon wafers.  
The resulting period:ridge widths for the six patterned 
surfaces were as follows; 400:70, 800:250, 1200:400, 
1600:650, 2000:850 and 4000:1900 (nm). Groove 
depths were 600 nm 
PC12 cells 
It was verified that the scale of substratum features can act 
supportively with sub-optimal growth factor concentrations 
acting as chemical cues to stimulate neurite extension 
Folei et al., 2005 
[311] 
Lines are fabricated by standard photolithography 
methods 
Neurons from adult medicinal 
leeches 
Neuronal processes, which are of micron size, have strong 
interactions with ridges even as low as 10 nm in which the 
interactions depend on the ridges’ height 
Baranes et al., 
2012 [312] 
Varying micro and nano-scale geometries: resorcinol–
formaldehyde (RF) gel derived carbon films and 
electrospun nanofibrous (∼200 nm diameter) mat and 
SU-8 (a negative photoresist) derived carbon micro-
patterns 
Neuroblastoma cells and SCs 
The in vitro studies on such carbon scaffolds using neural 
cells confirm that SCs are more adaptive towards topographic 
cues than undifferentiated N2a cells  
Mitra et al., 2013 
[313] 
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Figure 9 
Cells were stimulated or co-stimulated with NGF and other neuronal factors like 
forskolin. It was found that the presence of Forskolin diminished the phenomena of 
neurite alignment to the nanogratings which was related to the inhibition of focal 
adhesion maturation necessary for the alignment to occur.  
In a pioneer work, Foley et al. [311] addressed the question of which role topography 
might play in promoting neuritogenesis, since the phenomena of contact guidance has 
been well established before. For that, the authors cultured PC12 cells within an array of 
NGF concentrations on surfaces with ridge sizes ranging from 70 nm up to 1900 nm. 
Interestingly, it was found that with sub-optimal or lower concentrations of NGF, the 
neuritogensis was reinforced by topographic feature size. Also, contact guidance would 
happen to feature sizes as small as 70 nm. These results propose that topographic 
features can act compliantly with NGF signaling to regulate the formation and 
development of neurites.  
Baranes et al., [312] used photolithography to produce matrices with line-pattern ridges 
in the nano-scale dimension. By using neurons isolated from the CNS of adult leeches, 
they found that majority of the neuronal processes that approach ridges of 75 nm and 
higher are affected by the ridge and change their original growth direction, as seen in 
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Figure 9B. Also, there are two parameters that, according to them, must be considered 
when predicting the probability of a neuronal process to be affected by the ridge: the 
ridges’ height and the neuronal incoming angle, since for low ridges, the larger effective 
membrane surface due to acute incoming angles compensates the lack of adhesion 
surface. 
CNT can also be considered as a kind of nano-scale surface texture. Megan et al. [112] 
was able to very that motor neurons on grow and aligned when seeded over thin films of 
horizontally aligned CNTs. 
Mitra et al., [313] also worked with carbon materials, this time in a study that involved 
textured carbon substrates which were planned for investigation of neural cell 
performance and cytocompatibility. Nano-scale geometries in materials like resorcinol–
formaldehyde gel derived carbon films and electrospun nanofibrous (200 nm diameter) 
mat derived carbon micro-patterns were tested with results showing that textural 
features from 200 nm (carbon fibers) were found to affect neurite outgrowth. 
Furthermore, regardless of the randomness of carbon nanofibers, they promoted 
preferential differentiation of N2a cells into neuronal lineage, showing the importance 
of the nano-scale topography.  
With the above reviewed works, it is our feeling that it would be interesting to further 
explore the lower limit of neuronal sensitivity to nano-scale topographic cues and the 
resolution of that sensitivity. 
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4. Nanotheranostics and imaging  
The concept of theranostics relies in the combination of both therapeutics and 
diagnostics in one set. It is based in the image-guided therapy and also defining the 
treatment outcome at an early stage [314]. Theranostics should provide a visualization 
and tracking of imaging-labeled components not only for the diagnosis of the problem, 
but also possibly assessing the biodistribution of a therapeutic drug during treatment or 
specific molecular target [315]. 
Up to date, whenever an injury to PN is confirmed in the clinic context, the standard 
diagnosis is generally based on a fusion of simple clinical examination findings by the 
physicians and neuroelectrophysiology approaches [316]. Consequently, the diagnosis 
precision is often reduced since the two approaches mentioned before do not provide 
satisfactory information for the needed surgical repair, which in turn leads to improper 
treatments and poor outcomes for the patients, which results in life-long disabilities. 
The fact that injuries vary according to patient populations, etiologies, age and 
complexity of the injuries are co-adjuvant of this problem. The alarming consequences 
of PNI are not because of the injury itself, but due of the poor diagnosis and delayed 
time of medical action [317, 318].  
Furthermore, whenever a treatment like surgery is applied, there is a complete lack of 
monitoring tools and reliable non-invasive strategies to assess the consequent 
degeneration or axonal regeneration into the distal segment [319]. 
Therefore, there is a pressing medical need for the development of reliable and 
reproducible, non-invasive imaging strategies [320]. Such imaging strategies must have 
adequate spatial and temporal resolution for the early and exact diagnosis assessment of 
PNI as well as continued monitoring after treatment [321]. Consistent, harmless, 
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noninvasive and reproducible methodologies that aid in the determination of the injury 
degree and nature are required for the correct diagnosis, for instance to help in finding 
the exact location where changes in the normal nerve anatomy occurred. Once the 
diagnosis is correctly made, “regenerative tracking” and longitudinal monitoring of 
nerve regeneration, followed by treatment with neurotherapeutics holds great promise to 
achieve well-timed and precise treatments of PNI [322].  
A few imaging techniques have been exploited for PNI, both in the scientific and pre-
clinical settings, such as optical imaging, positron emission tomography computed 
tomography, magnetic resonance imaging, high resolution ultrasound and nuclear 
medicine [318, 323-326]. Nevertheless, despite the promising advances in the literature, 
it remains clinically difficult to apply noninvasive imaging technologies, since most 
require general improvement to be considered as a standard method [327].   
Now a days, there are two main methods used for imaging of PNS. The first is 
ultrasound, thanks to it wide availability and spatial resolution. Its use has clearly 
established indications and is particularly useful for PNS tumors. MRI is commonly 
considered as the second-line imaging method, aiming at providing decisive additional 
information thanks to its excellent contrast resolution. Both technologies are robust and 
widely spread in the clinic. Also, one has to consider the strong benefit of being able to 
examine the perineural environment, which cannot be evaluated by clinical examination 
alone or by electroneuromyography [328]. 
However, despite the panoplies of imaging methods mentioned before, it has been 
discussed previously that, in summary, MRI is the one that offers most promising 
results when in combination with nanotechnology, therefore is considered the best 
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potential tool for PNI. MRI uses a robust magnetic field to generate a magnetization in 
the tissue, followed by a disruption of magnetization with a brief radio pulse [329]. 
In one hand, the resolution of the standard MRI is within the range of hundreds of 
microns which goes against the possibility of using it for visualizing axons which are 
from 5 to 10 µm. On the other hand, high definition MRI-based imaging techniques are 
highly specialized, very expensive and logistically restricted, so most often unreachable 
by patients who need it [330]. As a result, nano-systems tactics allied to MRI for 
molecular and cellular imaging after PNI must be highly considered. Furthermore, these 
systems that would allow visualizing the true cellular behaviors and molecular complex 
phenomena that take place after injuries of each patient would gratefully contribute to 
personalize medicine and provide a patient specific therapy. In our opinion, 
nanotechnology is the way to address this need.  
NPs such as iron oxide NPs are an especially useful tool in nano-systems based 
imaging. They are highly sensitive contrast agents that can be up-taken by cells and 
their position changed by magnetic fields and located by MRI [331].  
Perfluorocarbon (PFC) nanoemulsions are also considered as attractive nano-
components as imaging platforms [332]. They are highly biologically inert and easily 
detected by MRI [333]. Table 11 summarizes the approaches envisioned for 
nanotheranostics and nanoimaging comprising nanotechnology in the field of PN 
regeneration [321, 334-339]. Also, Figure 10 reveals some of the most exciting results 
obtained in the field of theranostics and nano-imaging. 
Zheng et al., [321] described a molecular and nano-scale imaging methodology, namely 
molecular and cellular MRI (MCMRI).  Based on the fact that there are cellular and 
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molecular changes on the nervous system, both at proximal and distal sites after an 
injury, 
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Table 11 - Theranostics and nanoimaging applied to peripheral nerve regeneration. 
PNR imaging with 
MRI 
Type of nanomaterial 
Cell type or animal 
model 
Main result References 
USPIO labeling protein 0 (P0) and PMP 22 
kDa 
Not applicable 
The developed MRI probe would allow for 
imaging the PN targets in vivo 
Zheng et al., 2014 
[321] 
USPIO conjugated with MRI 
A model of neuropathic in 
rat sciatic nerve 
Animals with neuropathic pain in the left 
hindpaw show increased trafficking of 
USPIO-laden macrophages to the site of 
sciatic nerve injury 
Ghanouni et al., 2012 
[334] 
USPIO, Molday ION Rhodamine B (MIRB) Rat Neural Stem Cells 
Although USPIO particles, such as MIRB, 
may have advantageous labeling and 
magnetic resonance-sensitive features for 
NSC tracking, a further examination of their 
effects might be necessary before they can be 
used in clinical scenarios of cell-based 
transplantation due to exaggerated MRI 
signal dropout in the animals 
Umashankar et al., 
2016 [335] 
 SPION-labeled cells 
GFP-expressing ADSCs; 
mice sciatic nerve defect 
Histological analysis and 
immunohistochemistry confirmed the axon 
regeneration firstly revealed by MRI 
Li et al., 2013 [336] 
Imaging of 
neuroinflammation 
Perfluorocarbon nanoemulsion, which is 
phagocytosed by inflammatory cells  
Autoimmune 
encephalomyelitis rat 
The in vivo MRI results were confirmed by 
extremely high-resolution 
19
F/
1
H magnetic 
resonance microscopy 
Zhong et al., 2015 
[337] 
Perfluorocarbon nanoemulsion, which is 
phagocytosed by inflammatory cells  
Chronic constriction injury 
in rat 
The results demonstrate that the infiltration of 
immune cells into the sciatic nerve can be 
visualized in live animals using these 
methods 
Vasudeva et al., 2014 
[338] 
Perfluorocarbon nanoemulsion Rat sciatic nerve 
19
F MRI allows in vivo visualization of 
inflammation in the peripheral nervous 
system. Inflammation is detected 
unambiguously with high spatial resolution. 
Quantification of the fluorine signal is 
Weise et al., 2011 
[339] 
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possible with ex vivo 
19
F spectroscopy 
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Figure 10 
the authors hypothesized that in vivo PN targets can be imaged using MCMRI with 
specific probes, based on injured nerve specific proteins as targets. That was achieved 
by using a molecular antibody fragment conjugated to iron NPs as an MRI probe. The 
options considered were protein 0 (P0) and PMP 22 kDa as PNs specific target proteins, 
since the exclusivity of the targets in PNs is the basis of this hypothesis.  
To be able to get an image, such antibodies fragments were conjugated to ultra-small 
super paramagnetic iron oxide (USPIOs), which shortens the transverse relaxation of 
hydrogen proton and influence the imaging signal intensity and enhances the contrast. 
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However, for this hypothesis to be successful, it is essential that the probes have good 
bio-distribution and are able to surpass the blood-brain barrier and have its deposition 
done in PNs. 
In another study, Ghanouni et al., [334] used USPIOs conjugated with MRI to monitor 
macrophage trafficking, with the purpose of determining whether minocycline 
modulates macrophage trafficking to the site of PN injury in vivo and, in turn, results in 
altered pain thresholds.  In fact, Animals with neuropathic pain in the left hindpaw show 
increased trafficking of USPIO-laden macrophages to the site of sciatic nerve injury, 
which might contribute to the anti-nociceptive effect.  
Umashankar et al., [335] performed a comprehensive examination of rat NSC survival 
and regenerative function upon labeling with a specific kind of USPIO, named Molday 
ION Rhodamine B (MIRB), which allows for dual MRI and optical imaging. They 
observed that both MIRB doses (20 and 50 μg/mL) supported the robust detection of 
NSCs, over an extended period of time in vitro and in vivo after transplantation into the 
striata of host rats, using MRI and fluorescence imaging. However, animals receiving 
the 50 μg/mL MIRB-labeled NSCs, had an immune response consisting of an increased 
number of CD68(+)-activated microglia, which appeared to have phagocytized MIRB 
particles and cells contributing to an exaggerated MRI signal dropout in the animals. 
 Li et al., [336] investigated the feasibility of the use of MRI to noninvasively track the 
role of ASCs in the repair of PNI in vivo. For such, the authors isolated, expanded and 
differentiated Green fluorescent protein (GFP)-expressing ASCs into SC-like phenotype 
(GFP-dASCs) at early passages and subsequently labeled with SPIONs. The results 
showed GFP-dASCs were efficiently labeled with SPIONs, without affecting their 
viability and proliferation. The labeled cells implanted into the mice sciatic nerve 
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conduit exhibited a significant increase in axonal regeneration compared with the empty 
conduit and could be detected by MRI. Some images of such results can be seen in 
Figure 10A. 
In other approaches, the MRI technique has been mainly used to detect the migration of 
immune cells in living organisms, which contributes to the adequate understanding of 
the pathologies [337, 340]. 
Also, the understanding of the neuroinflammation process is of extreme importance, as 
a comprehensive approach on this parameter will give clues about neuronal 
regeneration, since there is an intrinsic connection between the injury and the 
consequent process of inflammation. Also, the process of neuroinflammation changes 
during the course of the injury and respective restorative pathway. Therefore, it can be 
used to monitor the variable progress from individual to individual, using MRI as the 
most promising imaging technique. Fortunately, monocytes and macrophages are key 
players in the neuroinflammation process and are also extremely reachable to be used as 
cellular targets, since they usually phagocyte the imaging agents or NPs injected in the 
blood stream [341]. 
Zhong et al., [337] evaluated the ability to noninvasively image and quantitate disease 
pathology using emerging “hot-spot” 19F MRI methods in an experimental autoimmune 
encephalomyelitis rat. Once again, PFC nanoemulsion was used and injected 
intravenously, which labeled predominately monocytes and macrophages in situ. Once 
again, the analysis of the spin-density weighted 19F MRI data enabled quantification of 
the apparent macrophage burden in the central and peripheral nervous system and other 
tissues, as can be seen in Figure 10B. 
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Vasudeva et al., [338] hypothesize that the infiltration of immune cells into the affected 
sciatic nerve could be monitored in vivo by molecular imaging. To test this hypothesis, 
an intravenous injection of a novel PFC nanoemulsion, which is phagocytosed by 
inflammatory cells, was used in a rat chronic constriction injury model in the sciatic 
nerve. To monitor the events, the nanoemulsion carries two distinct imaging agents, a 
near-infrared (NIR) lipophilic fluorescence reporter and a 19F MRI (magnetic resonance 
imaging) tracer. They have demonstrated that NIR fluorescence is concentrated in the 
area of the affected sciatic nerve as well as the 19F MRI signal, as can be seen in Figure 
10C. That was proven to be true when histological examination revealed significant 
infiltration of CD68 positive macrophages. 
Weise et al., [339] established 19F MRI for cell tracking in the PNS of rats. In their 
experiment, in order to induce neuroinflammation, lysolecithin was injected directly 
into the left sciatic nerve which lead to demyelination followed by severe infiltration of 
monocytes/macrophages. In fact, and as a proof of concept, systemic administration of 
PFC led to a fluorine signal along the proximal stretch of the affected sciatic nerves 
in in vivo 19F MRI which was not seen on the right healthy side. An In vivo 19F MRI 
performed 5 days after induced nerve injury can be seen in Figure 10D. 
Despite the reviewed promising advances, noninvasive imaging of PNI remains in its 
infancy in the clinic. In this specific field, it is essential that pharmaceutical industries 
take a leading role so that translation of innovative technologies is accelerated from the 
bench to the clinics. 
4.1. Nanotheranostics toxicity 
In the nanotheranostics field, PFCs have attracted a great deal of attention in the last 
decade. Two main factors contribute to the high positive impact of PFCs: (i) the lack of 
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natural endogenous background signal in vivo and (ii) the high NMR sensitivity of 
the 19F atom. These make PFC nanoemulsions ideal agents for cellular and magnetic 
resonance molecular imaging [342]. 
The wide range of drugs that PFCs can incorporate represent another advantage. Its 
core is surrounded by a lipid monolayer that can be functionalized to contain various 
agents for imaging or therapeutic action [343]. Despite the high toxicity presented by 
many drugs of interest, namely anti-tumor drugs, the use of such nanoemulsions can 
increase the degree of tumor targeting while diminishing its undesired secondary 
effects [344].   
Analyzing PFCs toxicity, the tissue clearance time varies based on the chemical 
compound. These tissue half-lives range from 4 days to 65 days [345]. Clearance of 
PFCs takes place not through metabolism, but through slow dissolution back into the 
circulation by the lipid carriers in the structure being, in a last step, removed through 
expiration [345]. 
In a study developed by Zhong et al., [346] PFCs showed uptake at 24 h primarily in 
the liver, followed by spleen and lung, with minimal uptake in kidney and heart, with no 
binding to the brain. Indeed, no negative change was seen in animal body during the 
time of the study, even with multiple nanoemulsion administrations.  
At this point of research, all the findings point to the potential of nanoemulsions for 
accurate organ/cell targeting while imaging at the same time, with no apparent toxicity, 
being considered one of the greatest advantages in the medical field.  
Still in the field of theranostics, iron oxide contrast agents, well known as USPIOs, have 
been combined with magnetic resonance imaging for cell tracking. There are two main 
reasons why these nanoparticles need to be coated. The first is related to the fact that 
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iron nanoparticles interact with each other in two forms: magnetically and via van der 
Waals’ interactions, leading the NP to flocculate [347].  
The second reason is related to their cytotoxicity, as uncoated NP have been shown to 
have up to a six-fold increase in cytotoxicity compared to dextran-coated iron NP. That 
cytotoxicity is mainly related to the creation of ROS, reduction of cellular proliferation 
and induction of cell death [348].  
When it comes to USPIOs elimination by the body, they are phagocytosed by the 
reticuloendothelial system from the blood pool. These nanoparticles are typically taken 
up by macrophages and phagocytic cells in the liver, bone marrow, and spleen. 
Afterwards, the lysosomal compartments of macrophages gradually degrade the iron 
nanoparticles [349]. 
USPIO’s have been reported to have an intrinsic toxicity that can be overcome by 
means of performing a surface coating with a biocompatible polymer, therefore 
increasing its potential to be used in the medical practices. Such demonstration has been 
made in a study by Neuwelt et al.,[350] where it was concluded that USPIOs agents are 
a viable a more safe option for patients which cannot use the typical Gadolinium based 
contrast agent due to chronic kidney disease.  
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5. Final remarks and future perspectives 
Peripheral nervous injuries are a public-health problem and recent achievements within 
the nanotechnology area, in particular to what concerns the development of advanced 
nanomaterials are expected to revolutionize novel therapies and provide improvements 
to current diagnostic and treatments.   
Furthermore, with nanotechnologies, the medical community is able to perform a more 
precise determination of the extent of the neuronal damage, which enables a better 
diagnosis, thereby leading to a proper treatment and improvement of the consequent 
outcomes, instead of just using the old functional evaluation of the damaged nerve. 
It is believed that current pre-clinical successes of nanotechnology can and should be 
adopted and adapted to the science of PNs regeneration and reconstruction. Not only 
that, but the described technologies should have a future in the clinics, since their 
benefits are immense. There are several significant PNR challenges which have not 
been fully addressed yet, despite decades of research. Poor vascularization, guided 
tissue regeneration, excessive fibrosis and neuroinflammation are some of those 
hurdles 
Carbon nanomaterials, which are characterized by their excellent electrical properties, 
are of full interest when considering that electrical stimulation is beneficial for PNR. 
Allied to the fact that it is possible to conjugate other molecules and that carbon 
nanomaterials can be arranged in specific topographies, the outcomes are overall 
improved when they are used as neuronal cellular substrates, either alone or in 
conjugation with other materials. 
Nanoparticles have the widest spectrum of benefits, since their purposes are endless: 
they can be used to just improve any materials’ bulk properties, to deliver growth 
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factors in a controlled and dependent manner or be used to label and track cells. This is 
useful not only to better understand the mechanisms of naturally occurring PNR, but 
also to provide a permissive and encouraging environment for the regenerative process. 
Due to the aligned and nano-scaled nature of PNS components, nanofibers and nano-
topographic cues are essential as physical cues and provide the guidance that PNs 
requires for a successful regeneration.  
Finally, nanotheranostics and imaging allow to improve not only the diagnostic process, 
but also the course of treatment after PNIs. Recently developed contrast agents allow 
clear visualization of PNR phenomena, such as inflammation, pain and the regeneration 
itself, depending on the targeted cells and contrast agents used.        
All of the above-mentioned nanotechnologies have a promising role in the clinics, since 
the outcomes are always improved in their presence. However, at this stage, it is 
fundamentally important to assess each nanotechnology safety, efficacy and quality, in 
order to be able to make that fundamental clinical translation.  
The aforementioned sections overviewed the current nanomaterials, strategies and 
different approaches that scientists have been working on, that gives an insight into the 
dynamics of damage and regeneration of PNs and their cellular components.  
In our perspective, nanomedicine is a field that can highly contribute to solve many 
problems related to the regeneration of partial nerve damage verified in most patients. In 
one hand, the design of TCs implantable devices comprising either carbon 
nanomaterials, NPs or nanofibers can provide a wide range of benefits, as a better 
substrate for neuronal cells, topographical cues that guide axons, adhesion points and 
optimized drug delivery. From a physio-pathological point-of-view, those features are 
necessary when envisioning a future medical device for PNR, for which such 
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technologies should keep being sought. On the other hand, theranostics are the tools of 
future in any medical field, which permit real time imaging and a personalized 
treatment. When correctly developed and applied, as seen in a few publications herein 
reviewed, theranostic approaches can fill the gaps that currently exist in the clinics and 
potentiate the technological translation from the bench to the clinics. We believe that by 
combing several nanotechnological strategies together, every step of the patient care 
since he enters the trauma room will be eased, improved and personalized. That is the 
consequence of better and faster diagnosis, precise treatment and follow-up. 
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Figure Legends 
 
Figure 1 – Nanotechnology applied to peripheral nerve regeneration and 
reconstruction. Carbon nanomaterials, nanoparticles, nanofibers, nano-topographic 
cues and theranostics and nano-imaging are some of the areas in nanomedicine that 
should are being explored in order to improve tissue biofunctionality. 
Figure 2 – Schematic representation of the anatomy of peripheral nerve and 
degeneration and regeneration after an injury. A) Scheme of peripheral nerve 
anatomy); B) Degeneration and regeneration after peripheral nerve injury.  (I) Normal 
neuron; (II) Wallerian degeneration. Schwann cells proliferate, and macrophages invade 
the distal nerve segment and phagocytosis of degrading materials; (III) Schwann cells in 
the distal end align in bands of Bungner; and (IV) Axonal re-joining with distal end and 
organs; and C) Axonal sprouts advance entrenched with aligned Schwann cells. 
Reprinted and adapted from A) [351]; B) [18]; C) [14]. 
Figure 3 – General phenomena impairing peripheral nerve regeneration, such as 
inflammation, excessive scar tissue or lack of vascularization. A) Macrophage 
plasticity in tissue repair, where M1 pro-inflammatory macrophages can change 
phenotype into M2 pro-regenerative macrophages; B) After injury, fibroblasts that are 
attracted to the injury site deposit excessive collagen that leads to perineural adhesions 
and intraneural fibrosis; and C) Macrophage-induced blood vessels guide Schwann cell 
to cross the nerve gap. Reprinted and adapted from A) [67]; B) [320]; C) [76]. 
Figure 4 – Carbon nanomaterials structure and their application of in peripheral 
nerve regeneration. A) (I) Single and multi-walled carbon nanotubes schematic 
structure. (II) Nanodiamond schematic structure.  B) Schematic representation of the 
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aligned PGF bundle interfaced with carbon nanotubes for neurite outgrowth. C) DRGs 
neurite outgrowth can be promoted by 50 mV/mm electrical stimulation or inclusion of 
20 μg/mL SWCNTs. The occurrence of both has a synergistic effect. D) Fluorescent 
nanodiamonds internalized into dissociated neurons. Confocal image of dissociated 
mouse cortical neurons cultured in the presence of 20 μg/mL fluorescent 
Nanodiamonds, stained with Alexa Fluor 488-conjugated concanavalin-A and DAPI. 
Reprinted and adapted from A) (I) [352] and (II) [151]; B) [89]; C) [115]; D) [158]. 
Figure 5 – Magnetic nanoparticles applied to peripheral nerve regeneration. A) 
MNPs bind to the injured nerve and a magnetic field is applied, creating mechanical 
tension. This stimulates nerve regeneration in the direction forced by the magnetic field. 
This physical guidance is envisioned to direct more efficiently the regeneration of the 
injured nerve from the proximal toward the distal stump; B) Schwann cells-astrocytes 
confrontation assay. Magnetized Schwann cells (in green) and astrocytes (in red) were 
seeded in parallel stripes and were allowed to migrate and intermingle for 1 week under 
applied magnetic field; C) NGF gradients generated by MNPs are able to direct the 
growth of extending neurites from chick DRGs. (I) NGF-cNPs directed the extension of 
neurites from DRG. (II) Control cNPs had no effect on the directional outgrowth of 
extending neurites, and respective polar histograms (below); and D) Sagittal and axial 
MRI of experimental animals receiving MSCs in sciatic nerve gap. Animals were 
implanted with MSC-loaded nerve conduits and MRI images were taken at different 
time points post-implantation. Arrows indicate the visible location of Fe3O4 NPs-labeled 
cells. Scale bar: 1 mm. Reprinted and adapted from A) [183]; B) [185]; C) [191]; D) 
[188]. 
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Figure 6 – The effect of other nanoparticles in peripheral nerve regeneration. A) 
The use of gold nanoparticles in PNR: examples of epifluorescence images of NG108-
15 neuronal cells cultured with Au, PSS/Au, and SiO2/Au NRs and labeled with β-III 
tubulin (red) and DAPI (blue). The effect of PSS/Au and SiO2/Au NRs on the 
percentage of neurons with neurites is evident; and B) Doxycycline-inducible GDNF 
expression and respective regeneration scenarios in the distal sciatic nerves of 
experimental 3 weeks’ time point. Continuous GDNF expression (dox +/+) causes some 
axons to avoid the regenerative path; time-restricted GDNF expression (dox +/−) leads 
to unobstructed and profuse regeneration; White arrows indicate the direction of axonal 
regeneration (proximal to distal). Total magnification: 100x. Reprinted and adapted 
from A) [193]; B) [225].  
Figure 7 – The use of exosomes in peripheral nerve regeneration. A)  Representative 
transmission electron micrographs of Schwann cell-derived exosomes in DRG axons, 
after staining exosomes with p75NTR-gold labeling on their surface; B) Axonal 
regeneration of DRGs after vehicle (Ctrl) or exosome (Exo) treatment for 5 days. DRGs 
are stained for acetylated tubulin (Ac-Tub, green), Phalloidin-Rhodamine (Phall, red) 
and nuclei (DAPI, blue). Scale bar: 50 µm. Reprinted and adapted from [256]. 
Figure 8 – The application of nanofibers in peripheral nerve regeneration. A) 
Schematic representation of the electrospinning process; B) DRG axon outgrowth after 
fluorescent staining with β-tubulin (green) and DAPI (blue), when cultured on (I) 
Matrigel® coated coverslips without NGF (negative control conditions; (II) Matrigel® 
coated coverslips with 50 ng of NGF/ml in medium (positive control conditions); (III) 
DRGs seeded on 300 nm fibers; (IV) DRGs seeded on 600 nm fibers; (V) DRGs seeded 
on 1000 nm fibers; and (VI) DGRs seeded on 1300 nm fibers. Scale bar: 20 μm; C) 
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Representative images of DRGs cultured for 5 days on aligned and random scaffolds in 
the presence or absence of microspheres. Samples without microspheres were 
supplemented with 50 ng/ml of NGF. Aligned fibers direct neurite outgrowth. Scale bar: 
250 mm; D) Use of PPY/PLCL combined with electrical stimulation in peripheral nerve 
regeneration. (I) The animal operation procedure immediately after 15 mm conduit 
implantation; (II) Circle electrode implantation; (III) Harvested regenerated nerve at 8 
weeks post-implantation; and (IV) 8 weeks post-implantation histological section of the 
electrode contact site stained with H&E (white arrows indicate the electrode contact 
site). Reprinted and adapted from A) [276]; B) [281]; C) [291]; D) [297].  
Figure 9 – The influence of nano-scaled topographic cues on cellular behavior. A) 
Focal adhesion establishment by stimulating PC12 contacting nanogratings with 
increasing ridge width. EGFP fluorescent signal in PC12 cells differentiating on 
nanogratings with a ridge width corresponding to (I) 500nm; (II) 750 nm; (III) 1000 nm; 
(IV) 1250 nm; (V) 1500 nm; and (VI) 1500 nm. White arrows indicate the direction of 
the nanografting. Scale bar: 10 µm; and B) (I) Leech neurons growing atop control 
substrates pre-coated with concanavalin-A. No preferable growth direction can be 
detected; and (II) Leech neurons growing on nano-patterned substrates pre-coated with 
concanavalin-A. Pattern ridges of 25 nm in height. The neuronal branches attach to the 
ridges and the whole growth pattern is aligned according to the topographic cues. 
Reprinted and adapted from A) [309]; B) [312]. 
Figure 10 – The application of theranostics and nanoimaging in peripheral nerve 
regeneration. A) Images of SPION-labeled GFP-dADSCs sciatic nerve. (I) MR images 
of operated sciatic nerve 28 d after transplantation; (II) Photograph of nerve that has 
been transplanted with GFP-dADSCs; (III) Fluorescent images of the nerve that has 
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been transplanted with GFP-dADSCs; (IV) Positive control of I; (V) Positive control of 
II and (VI) Positive control of III. White arrows point to the regenerated sciatic nerve; 
B) In vivo and ex vivo 19F/1H MRI of experimental autoimmune encephalomyelitis rat 
shows 19F signal arising from the spinal cord and adjacent vertebral bone marrow, 
representing accumulation of inflammatory phagocytes; C) Perfluorocarbon 
nanoemulsion, which is phagocytosed by inflammatory cells, was used in a rat pain 
model. The nanoemulsion is a near-infrared (NIR) lipophilic fluorescence tracer. The 
images demonstrate that in live rats, NIR fluorescence is concentrated around the 
affected sciatic nerve or in the area where incision was made, both reporting the site of 
macrophages location; and D) In vivo 19F MRI performed 5 days after induced nerve 
injury. In each rat, the fluorine marker uptaken by macrophages could be exclusively 
found in the left affected thigh, to where macrophages migrated. Two small bilateral 
“hot spots” are illustrated close to the spine which represent draining lymph nodes 
where marked macrophages also accumulate; and Reprinted and adapted from A) [336]; 
B) [337]; C) [338] D) [339]. 
ACCEPTED MANUSCRIPT
